Do obesity and physical inactivity underlie the insulin resistance of aging? by Amati, Francesca
 DO OBESITY AND PHYSICAL INACTIVITY UNDERLIE THE INSULIN 
RESISTANCE OF AGING? 
 
 
 
 
 
 
 
by 
Francesca Amati 
MD, University of Geneva, Switzerland, 1994 
MS, Clinical Research (Translational research track), School of Medicine                           
University of Pittsburgh, 2008 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
Health and Physical Activity, School of Education,  
in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2009 
 
 ii 
UNIVERSITY OF PITTSBURGH 
FACULTY OF HEALTH AND PHYSICAL ACTIVITY AND SCHOOL OF MEDICINE 
 
This dissertation was presented 
by 
 
Francesca Amati 
 
 
 
 
 
It was defended on 
July 1, 2009 
and approved by 
 
Dissertation Advisor: 
Bret H. Goodpaster, PhD 
Associate Professor, Department of Medicine 
School of Medicine, University of Pittsburgh 
 
John M. Jakicic, PhD 
Professor, Department of Health and Physical Activity 
School of Education, University of Pittsburgh 
 
Fernando E. Boada, PhD 
Associate Professor, Department of Radiology 
School of Medicine, University of Pittsburgh 
 
Robert M. O’Doherty, PhD 
Associate Professor, Department of Medicine,  
School of Medicine, University of Pittsburgh 
 
 
 iii 
Copyright © by Francesca Amati 
2009 
 iv 
 
Insulin resistance (IR) is the hallmark of type 2 diabetes (T2DM) and can precede its onset for 
many years. Since the prevalence of T2DM is higher among older adults, it has been suggested 
that aging is associated with IR. While some studies support the concept of age-related IR, others 
support the hypothesis that IR may not be associated with aging but rather with lifestyle patterns 
linked with aging, such as physical inactivity and obesity.  
To determine the effects of older age on IR independently of physical inactivity and 
obesity, we compared 7 older and 7 younger normal weight sedentary volunteers matched by 
gender, body mass index (BMI) and physical inactivity. In normal weight sedentary subjects, i.e., 
after accounting for both obesity and level of chronic physical activity, aging per se was not 
associated with IR.  
To determine the effects of obesity on IR independently of age and physical inactivity, 
we compared 7 older normal weight sedentary subjects to 14 obese sedentary subjects matched 
by age, gender and physical inactivity. After accounting for both age and physical inactivity, 
obesity was associated with both peripheral and hepatic IR.  
To determine the effects of chronic exercise on IR independently of age and obesity, we 
compared 14 older endurance trained athletes to 7 normal weight sedentary subjects matched by 
age and BMI. Within subjects of similar age and body weight, and after adjusting for body fat, 
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higher physical activity was associated with greater peripheral insulin sensitivity, but not with 
greater hepatic insulin sensitivity.  
Intramyocellular lipids (IMCL) and fatty acid metabolites such as diacylglycerols (DAG) 
and ceramides (Cer) may play an important role in the pathophysiology of IR.  We demonstrated 
that intramyocellular triglycerides (IMTG) were higher but ceramide content was lower in 
athletes. Moreover, the distribution of DAG and ceramide species was different in athletes 
compared to obese sedentary subjects.  
In conclusion, these data indicate that IR is not associated with age per se but rather is 
determined by obesity and physical activity. This study further elucidates the association among 
intramyocellular lipid content, aging, obesity, physical activity and IR. 
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1 INTRODUCTION 
1.1 RATIONALE 
Insulin resistance is a crucial factor for the development of type 2 diabetes (1). Obesity has been 
linked with insulin resistance (2). The increasing prevalence of obesity and type 2 diabetes in the 
older population (3) has detrimental health and economic consequences (4).  
Since insulin resistance has been shown to precede the development of type 2 diabetes 
(5), and the prevalence of type 2 diabetes is higher among older adults, it has been suggested that 
aging is associated with insulin resistance (6). The literature on age-associated insulin resistance, 
however, is inconsistent. Some studies support the concept of age-related insulin resistance (7, 8) 
while others, at least in overweight and obese populations, have shown that insulin resistance 
may not be associated with aging but rather with lifestyle patterns linked with aging, such as a 
reduced physical activity (9) and obesity (10). Therefore, it is not clear whether insulin resistance 
associated with older age is secondary to acquired effects of physical inactivity and/or obesity. 
No studies have yet examined whether insulin resistance is a feature of older age in both 
normal weight and obese subjects (Specific Aim 1).  Moreover, while insulin resistance is 
associated with obesity in younger adults, the literature is sparse concerning whether obese older 
subjects are more insulin resistant than normal weight older subjects. Within a homogenous 
group of older overweight to obese men and women, our research group has observed that the 
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amount of body fat was not associated with insulin resistance (R2>0.01, p=0.99). This lack of 
association between body fat and insulin resistance suggests that generalized adiposity may play 
a relatively minor role in insulin resistance in older subjects. To our knowledge no studies have 
yet examined whether generalized obesity is associated with insulin resistance in the older 
population (Specific Aim 2).  
Physical inactivity is likely another key factor in determining insulin resistance as people 
age. Chronic physical activity (i.e. exercise training) enhances skeletal muscle insulin response 
through many mechanisms, including increases in glucose transporters (GLUT 4) and enhanced 
insulin signaling. Prior studies have shown that young athletes are more insulin sensitive than 
young sedentary subjects, but it is nor known whether older ‘Masters’ athletes are more insulin 
sensitive than sedentary older subjects after accounting for their body fatness (Specific Aim 3).  
 
In addition to defects in insulin signaling and lower GLUT 4 content within skeletal 
muscle, ectopic lipid deposition, defined as an excess accumulation of triglycerides in non 
adipose tissue such as within the muscle fibers (intramyocellular triglycerides, IMTG), are also 
positively associated with obesity and insulin resistance (11, 12). Furthermore, the accumulation 
of IMTG is often cited as being a key determinant in insulin resistance (13). In addition to 
playing an important role in obesity (14) and type 2 diabetes (15), ectopic fat deposition is also 
observed in common conditions such as aging (16) and physical inactivity (17). Paradoxically, 
regular physical activity (i.e. exercise training) improves insulin sensitivity while increasing 
IMTG (18). This observation has led several investigators to examine the hypothesis that IMTG 
do not directly affect insulin action, but, depending on the metabolic context, e.g., high turnover 
or utilization of this energy pool during physical activity, merely provide a surrogate for the 
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accumulation of potentially damaging lipid metabolites, namely diacylglycerols (19) and 
ceramides (20). It is not yet clear whether chronic exercise affects partitioning of fatty acids into 
and out of these various lipid pools. Moreover, it is not clear whether insulin resistance in aging 
may be due to excess accumulation of harmful lipid metabolites due to chronic physical 
inactivity and/or obesity. Based on the above, clinical investigations into the separate effects of 
aging, obesity and physical inactivity on insulin resistance and IMTG and other intramyocellular 
lipids (IMCL) are clearly needed.  
1.2 PURPOSE 
The purpose of this study was to separate the effects of aging, obesity and exercise on insulin 
sensitivity and intramyocellular lipids (IMCL), by performing three cross-sectional comparisons: 
1) To determine whether or not older age is associated with insulin resistance 
independently of obesity and of chronic exercise, insulin sensitivity was compared in younger 
normal weight sedentary subjects vs. older normal weight sedentary subjects.  
2) To determine whether or not obesity is associated with insulin resistance 
independently of physical activity specifically within older subjects, insulin sensitivity was 
compared in older obese sedentary subjects vs. older normal weight sedentary subjects.  
3) To determine whether or not chronic exercise training is associated with insulin 
resistance in older subjects independent of obesity, insulin sensitivity was compared in older 
normal weight sedentary subjects vs. older endurance-trained athletes.  
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1.3 SPECIFIC AIMS AND HYPOTHESIS 
1.3.1 Specific Aim 1: To examine the effects of older age on insulin resistance in 
sedentary subjects. 
Hypothesis 1 We hypothesized that normal weight younger subjects would be more insulin 
sensitive than normal weight older subjects, when matched by BMI and by physical activity level 
(all sedentary subjects).  
 
To test this hypothesis, we measured insulin sensitivity in sedentary normal weight older subjects 
and compared them to BMI matched sedentary normal weight younger subjects.  
 
This hypothesis would be supported if sedentary normal weight older subjects have lower insulin 
sensitivity, i.e., they would be more insulin resistant, compared with sedentary normal weight 
younger subjects.   
1.3.2 Specific Aim 2: To examine the effects of obesity on insulin resistance and 
intramyocellular lipids (IMCL) in sedentary older subjects   
Hypothesis 2.1 Sedentary obese subjects would have lower insulin sensitivity compared to age 
matched sedentary normal weight subjects.  
 
Hypothesis 2.2 Lower skeletal muscle insulin sensitivity in sedentary obese older subjects would 
be observed in the context of higher intramyocellular triglycerides (IMTG) and with higher 
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levels of lipid metabolites, including diacylglycerols and ceramides, compared to sedentary 
normal weight older subjects.  
 
To test these hypotheses, we measured insulin sensitivity, IMTG and lipid metabolites in 
sedentary obese older subjects and compared them to age-matched sedentary normal weight 
subjects.  
 
These hypotheses would be supported if sedentary obese subjects have lower insulin sensitivity 
and higher IMTG with a higher content of diacylglycerols and ceramides as compared with the 
sedentary normal weight subjects.  
1.3.3 Specific Aim 3:  To examine the effects of chronic exercise on insulin 
resistance and IMCL in older subjects. 
Hypothesis 3.1 Older endurance-trained ‘Masters’ athletes would have greater skeletal muscle 
insulin sensitivity compared to age matched sedentary normal weight subjects independently of 
their total body fat content.  
 
Hypothesis 3.2 Higher skeletal muscle insulin sensitivity in Masters athletes would be observed 
in the context of higher intramyocellular lipids (IMCL) and triglycerides (IMTG) but with lower 
levels of lipid metabolites, including diacylglycerols and ceramides, compared to sedentary 
normal weight older subjects. 
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To test these hypotheses we measured insulin sensitivity, IMCL, IMTG and lipid metabolites in 
sedentary normal weight older subjects and in Masters athletes.  
 
These hypotheses would be supported if sedentary normal weight subjects have lower insulin 
sensitivity with a higher content of diacylglycerols and ceramides but lower IMCL and lower 
IMTG compared to the Masters athletes. 
1.4 SIGNIFICANCE 
Older adults are at increased risk for the development of type 2 diabetes. In 2006, the prevalence 
of diagnosed diabetes among people aged 65 to 74 was 12 times that of people younger than 45 
years old (18.4% and 1.6%, respectively) (21). Insulin resistance is generally accepted to be a 
key factor for the development of type 2 diabetes. Age-related insulin resistance has been related 
to higher levels of intramyocellular lipids and lower oxidative capacity in skeletal muscle. These 
same phenotypes have also been commonly described as characteristics of obesity and physical 
inactivity. 
The 2003-2006 National Health and Nutrition Examination Survey estimated that about 
66% of US adults are overweight or obese. Among men and women of 65 or more years old, the 
prevalence was 78% and 70% respectively (22). The same survey estimated that 57% of the 
population over 65 years old was sedentary in terms of their leisure time physical activities (i.e. 
never engaged in any vigorous, moderate or light physical activities for at least 20 minutes per 
week). Given that diabetes, obesity and sedentary behavior follow the same epidemiological 
trend in the aging population, it is important to determine the separate effects of age, obesity and 
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physical inactivity on insulin resistance. This will help elucidate the etiology of insulin resistance 
and its underlying mechanisms.  
This study will provide novel information concerning the separate effects of chronic 
exercise, aging and obesity on insulin sensitivity and on IMCL. These hypotheses if confirmed 
would support the primary role of overweight, obesity and physical activity on insulin resistance 
in aging. This will be one more step towards the understanding of the separate influences of 
aging, lifestyle (or decline of physical activity) linked with age. This will provide valuable 
evidence concerning the importance of physical activity and maintaining a healthy body weight 
in the prevention of metabolic diseases and with maintaining optimal health in older age.  
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2 REVIEW OF LITERATURE 
2.1 EPIDEMIOLOGY OF AGING, OBESITY, TYPE 2 DIABETES AND PHYSICAL 
ACTIVITY  
Obesity has become a major health care problem in developed countries. In the United States, 
about 32% of the adult population are obese (body mass index BMI>30kg/m2) and another 33% 
are overweight (BMI 25-30) (23). This prevalence is proportionately higher in older age groups 
(24). Even more disturbing is the observation that the incidence of obesity has increased from 
14% to 23% to 30% in each of the past decades (25).  
 Diabetes and the metabolic syndrome (a cluster of metabolic disorders including obesity, 
type 2 diabetes, hypertension and dyslipidemia) have followed the same pattern (26, 27). In 
2005, about 20.8 million persons had diabetes in the U.S., which corresponded to an estimated 
7% of the population (3). About 40% of all those diagnosed with diabetes were 65 years of age 
or older. That same year, the prevalence of diagnosed diabetes among people aged 65-74 
(18.5%) was about 12 times that in persons younger then 45 years of age (3). Worldwide, the 
prevalence of diabetes for all age-groups was estimated to be 2.8% in 2000 with the most 
important prevalence in the proportion of people >65 years of age (28). Type 2 diabetes accounts 
for about 90 to 95% of all diagnosed diabetes (3). The impact of the recent increase in incidence 
allowed the Centers for Disease Control and Prevention to project the total prevalence to more 
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then double from 2005 to 2050, with an increase of 220% among those aged 65-74 years and 
449% among those 75 years or older (29).  
 In 1997, the National Health Interview Survey conducted by the Centers for Disease 
Control and Prevention estimated that about 40% of U.S. adults were sedentary, defined as never 
engaging in any exercises, sports, or physically active hobbies in their leisure time. This survey 
is conducted yearly in the non-institutionalized civilian population (30). This proportion 
remained stable between 1999-2000 and 2005-2006. In 2005-2006, the proportion of Americans 
engaged in regular leisure-time physical activity declined with increasing age from 36% in 
young adults (18-29 years old) to 22% among older adults (65 years and over) (22). The 1996 
Surgeon General’s report on physical activity and health (31) emphasized the health benefits of 
moderate-intensity physical activities, especially everyday activities. In 2001 a new set of 
questions designed to measure occupational, household, and leisure-time physical activity with a 
special emphasis on moderate-intensity activities was included in the Behavioral Risk Factor 
Surveillance System (BRFSS), which is a population-based, random-digit–dialed telephone 
survey administered to U.S. civilian non-institutionalized adults. The prevalence of meeting the 
criteria (32) for moderate activity was similar for both men and women (32%), but was lower at 
older ages. The difference between the youngest (18 to 29 years) group and oldest (>75 years) 
group in meeting recommendations was slightly greater among women than men: 50% of 
women aged 18 to 29 vs 27% of women aged 75 or older, and 58% of men aged 18 to 29 vs 38% 
for men aged 75 or older (33). Population based studies in the USA (34) and in Europe (35) 
showed that a high level of physical activity is associated with a decreased likelihood of being 
obese.  
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2.2 INSULIN RESISTANCE IS RELATED TO OBESITY 
Insulin resistance (IR) can be seen as a state in which a cell, an organ, or the whole body, do not 
respond to normal amounts of insulin and thus requires higher than average levels of circulating 
insulin to elicit its normal physiological response (36). The staging of type 2 diabetes (T2DM) 
has been viewed as a continuum beginning with peripheral IR and ending with a loss of insulin 
secretion (1).  
 IR involves defects in multiple organ systems - muscle, the liver and adipose tissue- act 
together to produce abnormal glucose and lipid metabolism (5). Whole body IR can be measured 
in humans as well as specifically in the muscle, liver and in adipose tissue. Skeletal muscle 
accounts for approximately 80% of the insulin stimulated glucose uptake. IR in the muscle (37) 
and in the liver (38) can be present and precede for many years the onset of  T2DM (5, 37). IR is 
the principal mechanism by which obesity is considered to increase the risk for T2DM and is a 
key feature of the metabolic syndrome. 
 Research towards understanding how obesity leads to these chronic diseases has 
commonly included examination of regional adipose tissue depositions in addition to considering 
generalized adiposity influences on IR. Multiple cross-sectional and longitudinal studies have 
reported that fat accumulation in different adipose tissue locations have distinct metabolic 
consequences. Abdominal adiposity has been shown to be positively associated with IR and the 
metabolic syndrome in obese subjects (39) independently of total adiposity (40). Other adipose 
tissues depositions have also been shown to correlate with IR, among them the thigh adipose 
tissue (14). More recently, considerable attention has been paid to lipid accumulation in non 
adipose cells, i.e.. ectopic fat (41, 42).  
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2.3 INSULIN RESISTANCE AND ECTOPIC FAT DEPOSITION 
Excess accumulation of triglycerides within the muscle fibers (intramyocellular triglycerides, 
IMTG) is associated with obesity, IR, T2DM and the metabolic syndrome. This ectopic fat 
deposition (fat that is contained within non adipose tissue such as muscle) have also been 
associated with aging and physical inactivity. These lipid depositions are not inert; they are 
metabolically active and may be modified by diet and physical activity.  
 Skeletal muscle is considered one of the most important sites of IR. In this context, 
IMTG accumulation has been associated with systemic IR (11, 13, 43). Among sedentary 
subjects, there is an inverse association between IMTG and insulin sensitivity, furthermore, in 
one study, IMTG accounted for 32% of the variance of insulin sensitivity (18). Multivariate 
regression revealed that the association between IMTG and IR was independent of total adiposity 
and age. Other studies have reported associations between IMTG and obesity (44), with T2DM 
(15), aging (16) and physical inactivity (17).  
2.4 EXERCISE INCREASES INSULIN SENSITIVITY AND INCREASES THE 
CAPACITY FOR FAT OXIDATION  
Fat and carbohydrate oxidation are the dominant sources of aerobic energy production. The 
proportion of fat or carbohydrate utilization depends on many factors including the metabolic 
demand, e.g., fasting or exercise, intensity of exercise, the fitness level of the subject, and the 
availability of exogenous carbohydrates. Chronic physical activity (i.e. exercise training) can 
enhance skeletal muscle insulin action through many potential mechanisms: increases in glucose 
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transporters (45), in enzymatic activities (46), in fatty acid metabolism (47) and in mitochondria 
enzyme activity and number (8).  
2.5 EXERCISE, ECTOPIC FAT AND INSULIN RESISTANCE 
2.5.1 Intramyocellular triglycerides (IMTG)  
Although the basal content of IMTG has been shown in sedentary subjects to be related to IR, 
chronic exercise has been shown to increase IMTG in parallel with improved IR (18, 48); thus 
indicating an apparent paradox in the association between IMTG and IR (18). This has led to a 
view that IMTG accumulation per se does not directly affect insulin action but rather, under 
certain conditions, may act as a surrogate for other potentially harmful lipid metabolites, 
diacylglycerols (DAG) (19) and ceramides (Cer) (20), which have been identified as playing an 
important role in mediating fatty acid induced IR in muscle. It is possible that previous observed 
associations between IMTG and IR are influenced by the utilization of fatty acids within muscle 
as is likely the case in athletes. Thus under conditions of high fatty acid utilization, such as 
chronic exercise, the pool of fatty acids is in constant remodeling, thus preventing the 
accumulation of more damaging fatty acid metabolites within the cell (49). 
 Data examining the effects of exercise on IMTG in previously sedentary adults who are 
at risk for T2DM are limited. Pruchnic et al. demonstrated that previously sedentary older men 
and women performing 12 weeks of exercise had significant increases in IMTG, although IR was 
not directly measured in that study (50).  
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 The observation that IMTG are markedly higher in endurance-trained athletes, who are at 
the same time much more insulin sensitive than in sedentary subjects (18), led to the hypothesis 
that “the capacity to use fatty acids, …, during period of physical activity may mediate the 
influence of muscle triglycerides on insulin sensitivity” (12), thus the utilization of IMTG during 
acute exercise may play an important role in IR. IMTG content in the tibialis anterior and the 
soleus muscles is significantly reduced in endurance-trained men (51) and women (52) during 90 
to 120 minutes of moderate intensity exercise. A recent study confirmed that IMTG are utilized 
during exercise in proportion to their content (53).  Multiple studies confirmed the decrease in 
IMTG content after acute exercise in humans (51, 54-56). Replenishment of these stores has also 
been shown in the post-exercise state, particularly with high fat diets (57, 58). These studies 
support the concept that skeletal muscle lipids are a source of energy through oxidative 
metabolism during moderate physical activity (59). 
2.5.2 Potential role of mitochondria in the association between intramyocellular 
lipids (IMCL) and IR 
A potential mechanism for IMCL accumulation is a diminished fatty acid oxidation by muscle 
mitochondria (60). Many studies have reported a reduced rate of fat oxidation in the muscle of 
IR subjects (61), with a reduction of the enzyme complex transporting activated long chain fatty 
acids from the sarcoplasm into the mitochondria (carnitine palmityl transferase, CPT I and CPT 
II), whose activity is a key step in the regulation of fatty acid oxidation in muscle. A lower CPT 
activity has been shown to be proportional to an overall reduction in activities of diverse 
mitochondrial enzymes participating in the tricarboxylic acid cycle, electron transport chain and 
beta oxidation (10), thus this may reflect a reduced mitochondrial content, resulting in a reduced 
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capacity for lipid oxidation (12). Recently, we showed that obese sedentary older individuals 
could increase fat oxidation during a moderate exercise bout (62). Furthermore, exercise training 
increased insulin sensitivity, oxidative capacity and IMCL in these previously sedentary older 
subjects, while at the same time decreasing the fatty acid metabolites DAG and Cer (9), thus 
suggesting that it may not be IMTG per se but possibly these other lipid metabolites that mediate 
IR.  
2.6 AGE INCREASES INSULIN RESISTANCE  
There is a widespread assertion that aging leads to IR (6, 63) which is in turn fundamental to the 
etiology and higher prevalence of T2DM in older adults (4, 5, 28). The evidence behind the 
concept of age-associated IR, however, is conflicting. Studies supporting the ‘aging theory,’ 
which state that age-related insulin resistance is associated with mitochondrial defects (7, 8) are 
contradicted by reports demonstrating that insulin resistance may not be associated with aging 
per se but rather with lifestyle patterns linked with aging, such as a reduced physical activity (9) 
and obesity (10). Thus it is not clear whether insulin resistance is characteristic of aging, or 
alternatively, whether obesity and/or physical inactivity underlie this ‘aging’ effect.  
2.7 AGE, ECTOPIC FAT AND INSULIN RESISTANCE 
The relationship between intracellular fat accumulation and age-related IR has been examined in 
cross-sectional studies. Petersen et al. (7) found that higher IMTG levels in older compared to 
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younger subjects explained more severe insulin resistance in the former.  Two studies (16, 64) 
suggested that higher IMTG and intrahepatocellular lipids  in older men and women may explain 
age-related IR. This led multiple groups (65, 66) to hypothesize that these ectopic fat stores 
could explain age-related IR. This theory advocates that IR in the elderly is related to increases 
in IMTG and potentially other lipid metabolites that may be a result of a reduction in 
mitochondrial oxidative phosphorylation activity due to a reduction in mitochondrial number 
and/or function (67). What is not clear is whether this reduction of oxidative capacity is purely 
age-related or is secondary to acquired conditions that come with age, such as a decrease in 
physical activity and/or body composition changes.  
2.7.1 Age, body composition and insulin resistance  
In the Health, Aging and Body Composition (Health ABC) Study, an observational cohort of 
3,075 men and women aged 70-79 years, the prevalence of T2DM was 24% and an additional 
21% of subjects had impaired glucose tolerance (15). In this cohort, BMI was positively 
associated with IR. Furthermore two adipose tissue depositions were associated with IR 
independently of total body obesity: visceral adipose tissue and adipose tissue within the muscle 
(15). This led to the conclusion that IR in older men and women is strongly influenced by 
regional fat distribution, and specifically, abdominal fat and accumulation of fat within skeletal 
muscle. Additional studies in this cohort revealed that the association between body fat 
distribution and IR was strongest in those of normal weight (68). Similarly, a cross-sectional 
comparison between young and old subjects showed that the age-related decrease in insulin 
sensitivity was more strongly correlated with abdominal adiposity than to chronological age 
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(69). This begs the question of whether or not obesity or fat distribution may be underlying the 
age-related insulin resistance.  
2.7.2 Age, exercise and insulin resistance  
Mitochondrial dysfunction has been observed in the elderly compared to younger subjects in 
terms of reductions of decreased mitochondrial protein synthesis (70) and expression (67), 
oxidative phosphorylation capacity (7) and mitochondrial enzyme activity (71). However when 
comparing older to young athletes, some of these differences were no longer observed, with 
some mitochondrial enzymes actually being higher in master athletes compared with matched 
young runners despite a higher maximal aerobic capacity in younger athletes (72). Lower 
maximum heart rates and oxygen uptake in Masters athletes were also found in studies where 
athletes were matched for training programs (73).  In another cross-sectional comparison (74), 
glucose tolerance and insulin levels were similar in master athletes and in young athletes, which 
led the authors to conclude that “deterioration of glucose tolerance and insulin sensitivity is not 
an inevitable concomitant of the aging process and can be prevented by means of regularly 
performed exercise.” Other studies based on glucose tolerance tests confirmed that regular 
vigorous exercise can protect against the development of glucose intolerance with advancing age 
(75, 76).  
 When given an adequate training stimulus, the skeletal muscle of older previously 
sedentary subjects undergo adaptations including increased mitochondrial enzymes such as 
succinate deshydrogenase and citrate synthase (77, 78), increased mitochondrial respiratory 
capacity (79) and mitochondrial content (8).  Similar training programs have also increased 
similarly aerobic capacity in younger and older former sedentary subjects (80). The effect of 
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exercise training on IMTG and oxidative capacity has also been shown in older previously 
sedentary adults. Pruchnic and al. (50) demonstrated that 12 weeks of moderate exercise 
increased IMTG in older previously sedentary subjects and at the same time increased their 
oxidative capacity with a shift in muscle fiber type toward more oxidative type I fibers.  In this 
same population, the authors showed that exercise enhanced mitochondrial capacity (8, 81). 
Recently we found that moderate increases in physical activity in a similar population of older 
subjects were sufficient to increase IMTG and decrease both DAG and Cer in conjunction with 
improved insulin sensitivity (9). This begs the question whether or not physical inactivity may be 
underlying the age-related insulin resistance. 
2.8 ADVANCES IN INTRACELLULAR FAT DEPOSITION MEASUREMENT 
TECHNIQUES 
Until recently, the technique of choice to investigate intramyocellular lipid content was the 
biopsy by biochemical analysis or histochemistry (Oil red O staining) that measure specifically 
intramyocellular triglycerides (IMTG). However, drawbacks to this procedure include its 
invasive nature, along with the limitation that the measure is restricted to few muscle groups. 
Computed tomography (CT) has also been used to quantify adipose tissue infiltration within 
skeletal muscle (82), but has the limitations of its inability to quantify intramyocellular lipids 
(IMCL) and its use of ionizing radiation. Magnetic Resonance Proton Spectroscopy (1H-MRS) is 
a noninvasive in vivo method that allows quantification of intracellular lipid depositions.  MRS 
directly quantifies the chemical composition of a tissue (55), and can be used in combination 
with Magnetic Resonance Imaging (MRI) to obtain IMCL using image-guided, selective voxel 
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MRS. Validation of MRS techniques against direct tissue biopsy measures (biochemical and 
histological assays) in the muscle (83) has confirmed that 1H-MRS can quantitatively measure 
IMCL in vivo. Reproducibility with test/retest protocols has also been documented (84). Due to 
the advantage of MRS regarding multiple testing and its minimal risk, it is the technique of 
choice for repeated in vivo measurements of IMCL.  
 
2.9 UNANSWERED QUESTIONS  
 
Based on the above, it is not clear whether the obesity and the physical inactivity effects on IR 
are underlying any aging effect. In recent (unpublished) data, we found that the insulin 
sensitivity of obese middle age subjects is not different then obese old subjects (p=0.54). 
Although obesity may be a confounding effect on IR in aging, no studies have yet looked at the 
effect of age on insulin resistance independently of obesity (Specific Aim 1).   
While the association between obesity and insulin resistance is consistent in younger 
subjects, this may not be true in older adults. Indeed, our recent data indicate that the amount of 
body fat is not associated with insulin resistance in older subjects (R2=0.000001, p=0.99). This 
lack of association strongly suggests that other factors have an important role in insulin 
resistance in this particular population. To our knowledge no studies have yet examined the 
effect of obesity, independently of age, in the older population (Specific Aim 2).  
Chronic physical activity (i.e. exercise training) can enhance skeletal muscle insulin 
action through many potential mechanisms: increases in glucose transporters, in enzymatic 
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activities, in fatty acid metabolism and in mitochondria enzyme activity and content. Prior 
studies have shown that young athletes are more insulin sensitive then young sedentary subjects, 
but the effect of chronic exercise on insulin resistance, independently of obesity, has not been 
explored in older subjects (Specific Aim 3).  
2.10 SUMMARY OF LITTERATURE REVIEW 
Insulin resistance is a common state associated with acquired conditions such as obesity, 
physical inactivity and aging.  A possible mechanism underlying all of these conditions is the 
accumulation of lipid depots within muscle. This lipid deposition may be metabolically 
deleterious only in situations where they are inactive. Furthermore, only certain fatty acid 
metabolites seem to have a particularly negative effect on insulin action. Studies supporting an 
age-related mitochondrial decline in conjunction with insulin resistance are in contrast with data 
showing that obesity and inactivity, that in turn impact body composition and fat depositions, 
may be underlying this age effect. These controversial findings call for the need to examine the 
separate effects of aging, obesity and chronic exercise on insulin sensitivity, as well as a key 
correlates and potential mechanisms of insulin resistance, that is, intramyocellular lipid content.  
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3 RESEARCH DESIGN AND METHODS 
3.1 OVERVIEW OF THE STUDY 
3.1.1 Study design  
This study was designed to compare and contrast insulin resistance and potential underlying 
factors for insulin resistance in four groups of subjects that differed according to age, obesity and 
chronic physical activity levels (Table 1). To examine potential differences in insulin resistance 
according to age, younger (25 to 45 years of age) and older (60 to 75 years of age) were 
compared (Comparison 1). To examine potential differences in insulin resistance according to 
obesity within older subjects, two groups of older (60 to 75 years of age) subjects, one group of 
normal weight (BMI<26 kg/m2) and one group of obese (BMI>30kg/m2) were compared 
(Comparison 2). To examine potential differences in insulin resistance according to chronic 
physical activity (exercise training) levels within older subjects, two groups of older (60 to 75 
years of age) normal weight (BMI<26 kg/m2) subjects, one group of sedentary and one group of 
competitive athletes were compared (Comparison 3).  
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Table 1 Group matrix  
 
Middle age Athletes 
 
Middle age normal weight 
sedentary Middle age obese sedentary 
 
Older Athletes 
 
Older normal weight  
sedentary Older obese sedentary 
 
3.1.2 Subjects  
3.1.2.1 Subject recruitment and characteristics  
Data from younger normal weight subjects included for this project were obtained from a 
previous study conducted by Dr. Goodpaster and colleagues. Data obtained in the obese older 
subjects for this project were obtained from baseline assessments from ongoing weight loss and 
exercise intervention trials in which I conducted alongside Dr. Goodpaster and his research team. 
I specifically recruited the older normal weight sedentary subjects and athletes for this project.   
 
The inclusion/exclusion criteria applied to the two newly recruited groups (older normal 
weight sedentary and older athletes) were generally the same as the two groups that had been 
previously recruited. To qualify as ‘sedentary’, subjects were currently participating in one or 
less days per week of a structured exercise session of less then 20 minutes. To qualify as 
‘athletes’, subjects were currently participating in five or more structured aerobic exercise 
session per week for more than one year and competing in their sports at regional or national 
level. To qualify as normal weight, subjects BMI were <26 kg/m2. To qualify as obese, subjects 
were > 30 kg/m2. To qualify as ‘younger’, subjects were between the ages of 25 and 45. To 
1 
2 3 
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qualify as ‘older’, subjects were between 60 and 75 years of age. All volunteers were in good 
general health, nonsmokers, with stable weight, were recruited to satisfy the inclusion/exclusion 
criteria (see appendix B) and based on their willingness to participate.  
Recruitment was performed differently for the sedentary subjects and the athletes. For the 
older normal weight sedentary adults we used four recruitment methods: IRB approved study 
fliers (see appendix C) were posted on campus, 1,752 IRB approved letters (see appendix D) 
were sent to subjects on the ‘Pepper Center Registry’ and to University of Pittsburgh faculty and 
staff in the 60+ age range, three ads were posted in the ‘UPMC extra’ newsletter and ‘Audix 
messages’ were posted on two different occasions. For the athletes, 89 IRB approved letters (see 
appendix D) were send to athletes on the ‘PA seniors athletes registry’, IRB approved fliers (see 
appendix C) were posted on campus, in multiple sports (running and bike) shops and were 
distributed on three local sporting events and expositions (the ‘Great race’, the ‘Tour of PA’ and 
the ‘Pittsburgh triathlon’), as well as in local cycling and running clubs.  
Older obese sedentary subjects were selected among baseline data available from subjects 
recruited from 2005 to 2007 of the SHELL (‘Study of Health and Exercise in Later Life’) and the 
MIRA (‘Muscle Insulin Resistance in Aging‘) studies. As the MIRA is an ongoing study, 
modifications of the IRB protocol, new informed consents, letters and flyers were created and 
approved to accommodate the two newly recruited groups (see IRB protocol letters of 
acceptance for modifications and informed consents in appendix E-G). The selection criteria for 
the older obese sedentary subjects in this cross-sectional comparison are described bellow 
(chapter 3.1.2.3).  
Younger normal weight sedentary subjects were selected among data from Dr. 
Goodapster’s earlier study (10, 85). In the exclusion/exclusion criteria the only difference with 
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the other three groups were that women on oral contraceptives were excluded. The selection 
criteria for the younger normal weight sedentary subjects in this cross-sectional comparison are 
described bellow (chapter 3.1.2.2). 
3.1.2.2 Specific Aim 1: To examine the effects of older age on insulin resistance in sedentary 
subjects. 
The subjects for the first cross-sectional comparison are presented in the figure 1. Older normal 
weight sedentary subjects were compared. Younger normal weight sedentary subjects were 
selected based on 1) their BMI ( >18 and <26 kg/m2 ), 2) availability of their clamp data, 3) their 
gender and BMI (± 1.5 kg/m2) for matching with the older normal weight subjects on a 1:1 ratio.  
Older normal weight sedentary
60-75 years old
BMI >18 to <26 kg/m2
Younger normal weight sedentary
25-45 years old
BMI >18 to <26 kg/m2
 
Figure 1 Cross-sectional comparison for Specific Aim 1 
3.1.2.3 Specific Aim 2: To examine the effects of obesity on insulin resistance and 
intramyocellular lipids in sedentary older subjects 
The subjects for the second cross-sectional comparison are presented in the figure 2. The same 
group of newly recruited older normal weight sedentary subjects was used in this comparison. 
Older obese sedentary subjects were selected based on 1) their BMI (>30 kg/m2), 2) availability 
of their clamp data, 3) to match gender and age (± 2 years old) with the older normal weight 
subjects on a 2:1 ratio. 
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Older normal weight sedentary
60-75 years old
BMI >18 to <26 kg/m2
Older obese sedentary
60-75 years old
BMI >30 kg/m2
 
Figure 2 Cross-sectional comparison for Specific Aim 2 
3.1.2.4 Specific Aim 3: To examine the effects of chronic exercise on insulin resistance and 
intramyocellular lipids in older subjects. 
The subjects for the third comparison are presented in the figure 3. Older athletes and older 
normal weight sedentary subjects were recruited. This later group was the same used in the two 
prior comparisons.   
Older normal weight sedentary
60-75 years old
BMI >18 to <26 kg/m2
Older athletes
60-75 years old
 
Figure 3 Cross-sectional comparison for Specific Aim 3 
3.2 VISITS AND OUTCOME MEASURES 
3.2.1 Overall protocol and Visits 
Subjects recruited from letters, fliers and ads, were asked to call our research coordinator. After 
explaining the study, a first consent was solicited thought the phone to perform a 10-minute 
phone screening including age, height, weight, current level of physical activity and major 
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illnesses.  A description of the study was given. If potentially eligible after the phone screening, 
the subject was scheduled for the screening visit at the Clinical Translational Research Center 
(CTRC) that included a history and physical examination (HP), oral glucose tolerance test 
(OGTT), weight and height. After a detailed explanation of the study and providing written 
informed consent, and if none of the exclusion criteria were met, the subject was enrolled. The 
three visits outlined in table 2 were scheduled within the month following the screening visit. 
Subjects were asked not to modify their physical activity pattern or their diet during this period.  
Visit 1 and 3 were outpatients visits. Visit 2 was an overnight visit.  
 
 
Table 2 Plan of visits and measures 
 
 
 
 
 
 
 
Visit 1 included body composition and physical fitness measures. Visit 2 included insulin 
sensitivity measure, indirect calorimetry and the muscle biopsy was performed. Visit 3 included 
the magnetic resonance imaging (MRI) and spectroscopy (MRS) measures. All these visits were 
exactly the same for all groups except for visit 3. The 2 newly recruited groups had a magnetic 
resonance scan for MRI to measure regional fat distribution and MRS, while the other two 
groups recruited in the past years had their adipose tissue distribution determined by computed 
tomography.  
Recruitment 
and phone screening 
Screening 
visit and 
Consent 
 
Visit 1 Visit 2 Visit 3 
Phone interview 
 
HP DXA Glucose Clamp MR Imaging  
Phone consent for 
Screening visit 
OGTT VO2 peak Muscle biopsy  1H-MRS 
 Consent  
 
Indirect calorimetry  
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3.2.2 Endpoint measures  
An hyperinsulinemic euglycemic clamp was performed to measure basal insulin 
sensitivity normalized by fat free mass (FFM) obtained by dual-energy X-ray absorptiometry 
(DXA). Intramyocellular triglyceride (IMTG) was measured histochemically in the muscle 
obtained by percutaneous biopsy. The biopsies also served for the measure of other 
intramyocellular lipids (IMCL), namely DAG and Cer; these were quantified using tandem mass 
spectrometry. For the newly recruited subjects, the IMCL measure will also be obtained in the 
tibialis anterior with Magnetic resonance spectroscopy (1H-MRS). Indirect calorimetry was used 
to derive whole body fat and carbohydrate oxidation. The main outcomes measures obtained are 
summarized in table 3.  
 
 
Table 3 Outcome measures 
 
3.2.3 Details of the visits and measurements  
3.2.3.1 Initial Screening Visit 
The screening visit took place after an overnight fast at the Clinical Translation Research Center 
(CTRC) located on the 6th floor of Montefiore Hospital (Pittsburgh, PA). A thorough screening 
visit description was given to the subject and time was given to ask questions about the screening 
Major Outcome Variables (procedures) Covariates 
Insulin sensitivity (glucose clamp) Total body fat (DXA) 
Intramyocellular lipids (biopsy, 1H-MRS) Total lean mass (DXA) 
Diacylglycerol and Ceramide (biopsy) Visceral Adipose Tissue (MRI or CT) 
Fat and carbohydrate oxidation (indirect calorimetry) Proportion of fiber type and oxidative capacity (biopsy) 
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procedure. A screening visit written consent was obtained before starting the screening 
procedures. The following measures were performed: 
1) Medical Health History and Physical conducted by a study physician.  The physical element 
of the exam included a standard physical exam including general assessment of the following:  
Head, ears, nose, eyes, throat, heart, lungs breast, abdomen, genitalia/rectal, extremities, skin, 
neurological functioning, and any other impressions or problems noted by the physician at the time 
of exam. Weight was measured on a calibrated medical digital scale (BWB-800; Tanita 
Corporation, Tokyo, Japan) fasted without shoes and subjects wearing minimal clothing. Height 
was measured at the same time with a wall-mounted stadiometer. Waist circumference was 
measured on the subjects standing and relaxing their abdomen, with a tension regulated tape at the 
midpoint between the lowest rib and the iliac crest on the mid-axillary line. This measurement was 
performed twice, and the average of the two readings was used. A third measurement was 
performed if the difference between the two readings was larger than 1 cm.  
2) A fasting blood draw for determination of lipid profiles (cholesterol, HDL, LDL, VLDL, 
triglycerides); electrolytes (sodium, potassium, chloride, carbon dioxide); blood glucose, CBC 
(Complete blood count); platelet count, HbA1c, kidney function (BUN, creatinine, and urinalysis); 
TSH, liver function (ALT, AST, Alk. phos).  All of these were processed through standard hospital-
certified laboratory protocols. Only subjects with values within the exclusion/inclusion criteria (see 
appendix B) were included in the study.  
3)  Oral Glucose Tolerance Test - Subjects ingested (within a two minute time period) a 75 gram 
glucose solution (Glucola). Blood samples were obtained at time 0 (prior to ingestion), 30, 60, 90, 
and 120 min following glucose ingestion. Sterile saline (1-2 ml) were infused periodically between 
samples to keep the catheter line patent. Subjects remained at rest at the CTRC until completion of 
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the test. Plasma glucose was measured in duplicate immediately following sampling using an 
automated glucose oxidase reaction (YSI 2300 Glucose Analyzer, YSI inc, Yellow Springs, OH). 
Plasma insulin was measured in batches with an Elisa kit (LINCO Research, St. Charles, MO). 
Following this screening visit, subjects were eligible to enter the study if no exclusion criteria 
were evidenced during the health and physical exam or on the results of the lab tests (see addendum 
B). Following the American Diabetes Association diagnostic criteria (86), only subjects with 
normal glucose tolerance (2h OGTT glycemia <140mg/dl) or impaired glucose tolerance (2h OGTT 
glycemia≥140 mg/dl but <200mg/dl) were included in this study, subjects with type 2 diabetes (2h 
OGTT glycemia≥200mg/dl) were excluded (see consent form for screening in addendum F). 
Subjects with medical or laboratory abnormalities were referred to their Primary Care Physician for 
follow-up (see exclusion criteria- appendix B). 
A complete study description was given to eligible subjects. Subjects had time to ask questions, 
and these were answered by the research coordinator, a study physician or the primary investigator 
(PI). Upon signature, the patient was entered into the study.  
3.2.3.2  Dual Energy X-Ray Absorptiometry (DXA) (Visit 1)  
At the first testing visit, research subjects were scheduled to have a body composition 
measurement. This test took place at the Obesity and Nutrition Research Center (ONRC) using a 
Lunar prodigy scanner and enCORE software 2005 version 9.30 (GE Healthcare, Milwaukee, 
MI). This DXA scanner is calibrated weekly. A whole body scan was acquired with the subject 
supine and aligned on the scanner table as prescribed by the manufacturer. The DXA was 
performed by a certified technician. This test allowed the measurement of their overall body fat 
mass, lean body mass and bone mineral content. No particular regions of interested were 
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analyzed. Fat free mass (FFM) was computed by adding their mineral content to the lean body 
mass, and was expressed in Kg. This was used to express insulin sensitivity relative to FFM.  
3.2.3.3 Peak Aerobic Capacity (VO2peak) (Visit 1) 
All subjects performed a cycle ergometer peak aerobic capacity test (VO2peak) to determine 
physical fitness. This test took place at the ONRC. An exercise physiologist with training in 
Advance Cardiac Life Support conducted all graded exercise tests (GXT).  A physician was 
present during the test.  Each subject performed a GXT, lasting 8 to 12 minutes, on an 
electronically braked cycle ergometer  (Sensormedics, Yorba Linda, CA) using a protocol well- 
suited for elderly individuals with a wide range of exercise capacities. The test consisted of an 
initial warming-up of 2 min with no load pedaling. The GXT began at 25 Watts for females and 
50 Watts for males as used in prior studies (50). Every two minutes the resistance was increased 
by 25 Watts until volitional exhaustion and one of the established criteria for VO2max had been 
reached (87). For the athletes, the resistance was increased by 50 Watts for the first three stages 
followed by 25 Watts increments until the same criteria as above were reached.  Heart rate, blood 
pressure and ECG were recorded before the test, at the end of each two minutes stages and 
during recovery for at least six minutes. Subjects breathed through a mouthpiece connected to a 
two-way breathing valve (Hans Rudolph, Kansas City, MO) during the test, and expired air was 
collected via an open-circuit spirometry to a computerized metabolic cart  (Sensor Medics CS 
2900, Yorba Linda, CA) to determine oxygen consumption (VO2) and carbon dioxide production 
(VCO2). The metabolic cart analyzed the data every 30 seconds. For safety purposes, our study 
cardiologist examined all the ECG. Subjects with ECG abnormalities were referred to their 
Primary Care Physician for follow-up and were excluded from the study if cardiovascular 
disease was confirmed (see exclusion criteria- appendix B). 
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3.2.3.4 The Hyperinsulinemic Euglycemic Glucose Clamp (Visit 2)  
An hyperinsulinemic euglycemic glucose clamp was performed to determine rates of insulin-
stimulated glucose disposal (Rd). This is the gold standard to measure in vivo insulin sensitivity (88). 
When coupled with stable isotopes it can distinguish and quantify skeletal muscle and hepatic insulin 
resistance. This procedure was performed at the CTRC under the supervision of the PI. On the evening 
before the clamp, subjects were admitted in the CTRC. They received a standard dinner (7.5 kcal/kg of 
body weight, 50% carbohydrates, 30% fat, 20% proteins) and then fasted until completion of the 
glucose and insulin infusion in the following day. Subjects were instructed not to perform physical 
exercise 48 hours before the clamp to avoid the acute effects of exercise on insulin sensitivity. On the 
day of the clamp, at ~5:30 A.M. a catheter was inserted in a prominent forearm vein for later infusion 
of glucose and insulin. A second catheter was inserted in a retrograde fashion into a dorsal hand or 
wrist vein of the opposite arm. The hand was warmed by a heating pad to 70∞C to “arterialize” the 
blood. After obtaining basal blood samples, a primed constant infusion of stable isotope of glucose 
[6,6-2H2] glucose (0.22 µmol/kg, 17.6 µmol/kg prime) 99% enriched (Cambridge Isotopes 
Laboratories, Andover, MA) was started with a calibrated syringe pump (Harvard Apparatus, Natick, 
MA), allowing 2 hours for isotopic equilibration before the initiation of the insulin infusion. This was 
continued during the insulin infusion to determine rates of systemic glucose utilization and to 
determine insulin suppression of hepatic glucose production. A continuous infusion of insulin 
(Humulin, Eli Lilly, Indianapolis, IN) was started at ~8 A.M. given at a rate of 40 mU/m2/min for 4 
hours, and euglycemia (Target Glucose = 90 mg/dl) was maintained using an adjustable infusion of 
20% dextrose (with [6, 6-2H2] additive). Blood samples were obtained every 5 minutes thereafter to 
determine plasma glucose levels and in order to adjust the infusion rate of the 20% dextrose. Blood 
samples for measurement of [6, 6-2H2] glucose enrichment were collected every 10 minutes during the 
 31 
last 40 minutes of the clamp (210, 220, 230 and 240 min). A total of about 300cc of blood (per 
subject) were taken during each CTRC overnight stay. Following completion of the clamp at ~12 
P.M., all subjects were given a lunch.  
Plasma glucose and insulin were measured using the same techniques and tools as described 
for the OGTT. Plasma [6, 6-2H2] glucose enrichment was determined by gas chromatography (Agilent 
6890 Series, Agilent Technologies, Santa Clara, CA) coupled to a Mass Selective Detector (Agilent 
5973 Network, Agilent Technologies, Santa Clara, CA). The analysis of the glucose penta-acetate 
derivatives was performed selectively monitoring ions at mass-to-charge 200 and 202.  
Rate of plasma glucose appearance and utilization were calculated using the Tracer-Tracee 
method with the Steele equations (89), as modified for variable rate glucose infusions which contain 
isotopes (90, 91). As at steady state, the rate of glucose disposal (Rd) is the sum of the hepatic glucose 
output (HGO) and the glucose infusion rate (GIR). The HGO and the percent suppression of the HGO 
(from baseline to the end of clamp) were also computed, allowing a measure of liver insulin 
sensitivity.  
3.2.3.5 Indirect Calorimetry (Visit 2) 
Indirect calorimetry was used to determine resting energy expenditure (REE), fat and 
carbohydrate oxidation after an overnight fast and in the insulin stimulated state (i.e. at the end of 
the hyperinsulinemic euglycemic clamp).  Indirect calorimetry, used to measure oxygen 
consumption (VO2) and carbon dioxide production (VCO2), was performed for 30 minutes using 
an open canopy system (Moxus, AEI Technologies, Pittsburgh, PA). Prior to every test, 
calibration of both gas and pressure were completed. After the overnight fast at the CTRC, at 
~6:00 A.M. subjects were placed under the canopy while resting in bed. They were told to close 
their eyes and try to sleep, refrain from fidgeting or to perform any type of activity (i.e. watching 
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TV or reading). The first five minutes of data collection were discarded to allow the 
computations to be performed on steady state measures. The same protocol was repeated at the 
end of the hyperinsulinemic euglycemic clamp (minutes 200 to 230).  
Systemic fat (Fat-ox) and carbohydrate (Cho-ox) oxidation rates were calculated using 
the stochiometric equations of Frayn (92). 
 
Equation 1 Systemic fat and carbohydrate oxidation 
 Fat-ox(mg/min) = 1.67 VO2(ml/min) -1.67 VCO2(ml/min) 
 Cho-ox(mg/min) = 4.55 VCO2(ml/min) – 3.21 VO2(ml/min) 
 
The Fat-ox value were then transformed into kcal/min and expressed as a proportion of 
energy derived from fat (EF). 
 
Equation 2 Proportion of Energy derived from fat 
 EF(%) = (Fat-ox(kcal/min) / REE(kcal/min))*100 
 
Protein oxidation rates were not included based on our prior work demonstrating that 
rates of urinary nitrogen excretion were similar in lean and obese subjects during resting 
conditions (93) and on the assumptions that the amount of proteins oxidized and other metabolic 
processes (such as gluconeogenesis from proteins, ketone body formation and lipogenesis) 
during resting and insulin stimulation (i.e. in the fed state) are quantitatively negligible compared 
to glucose and fatty acid oxidation (94).  
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3.2.3.6 Percutaneous Muscle Biopsy (Visit 2) 
Percutaneous muscle biopsies were obtained at the CTRC at ~7 A.M. thus following the 
overnight fast and in the same standardized conditions as described for the clamp, with a 
standardized meal for diner and no exercise in the last 48 hours to prevent acute effects of 
exercise on IMCL (59, 95). Muscle biopsies were obtained using 2% buffered lidocaine for 
anesthetic, a ~ 0.5 cm incision was made in the skin from the middle region of the vastus lateralis 
(15 cm above the Patella) and ~2 cm away from the fascia by percutaneous needle biopsy 
technique using previously published methods (10, 14, 18) adapted from Evans (96). About 100-
150 mg of muscle were obtained. The incision was closed with sterile adhesive strips, and a 
pressure bandage was applied for a period of 24 hours.  
Specimens were trimmed of any visible adipose tissue, mounted in OCT mounting-
medium (Miles, Inc., Elkhart, IN), and frozen in isopentane cooled at -160∞C by liquid nitrogen 
and stored at -80∞C for histochemical analysis. All specimens were stored at -80º C refrigerators.  
Histochemical analyses were performed at the ONRC as previously described (97, 98). 
Frozen tissue blocks were sectioned at -20°C (Cryotome E; Shandon Scientific, England) 10 µM 
thick and placed on individual pre-cleaned glass slides. Initial sections from each frozen muscle 
block were inspected without stain to ensure that proper cross-sectional cuts were being 
obtained. Muscle sectioning, staining and image analysis were performed by the same technician 
and done in a blinded manner with respect to subject. Each analysis included data from 80 to 300 
fibers, and intra-assay variability was <5% (9). 
IMCL was stained with Oil Red O soluble dye, which stains neutral lipid (mainly 
intramyocellular triglycerides; IMTG) (14, 18). After staining, a light microscope (Leica DM 
4000B, Leica Microsystems, Wetzlar, Germany) was used to examine the stained muscle 
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sections, using a x40 oil immersion objective and bright field settings. Images were digitally 
captured using a charge-coupled device camera (Retiga 2000R camera; Q Imaging, Surrey, BC, 
Canada) and converted to 16-bit gray-scale images. Contiguous fields of view within the biopsy 
section that were free from artifact were analyzed for lipid content. Semi-quantitative image 
analysis (Northern Eclipse software v.6.0, Empix Imaging, North Tonawanda, NY) was then 
carried out on at least 80 fibers, or ~10 contiguous fibers/field and normalized to background. A 
control section treated with acetone and subsequently stained revealed no visible background 
staining. After normalization to the background, the ORO value was expressed as an arbitrary 
unit (AU).  
 
Equation 3 Arbitrary unit for ORO 
 ORO(AU) = (ORO / mean ORO for all subjects in the analysis) 
 
Succinate deshydrogenase (SDH) staining (99, 100) was used as a marker for oxidative 
capacity of muscle. A stock solution was made with PBS, nitro blue tetrazolium, KCN, MgCL 
and distilled water as described elsewhere (50). This stock solution was then added into a 
working solution containing sodium succinate and menadione. Sections were incubated for 45 
minutes at room temperature then washed in distilled water. Quantification of SDH staining was 
performed using image analysis of staining intensity and normalized to background in the same 
manner as ORO staining. As a negative control, sections were incubated in media without the 
enzyme substrate succinate. SDH values were expressed in AU as described for ORO.  
The proportion of type I slow oxidative and type II fast glycolytic muscle fibers  were 
determined using immunohistochemistry as described elsewhere (9, 50). The slides were 
incubated with antibodies specific for type I and type IIa fibers (Santa Cruz Biotechnology, 
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Santa Cruz, CA). Signals for fiber specific were recorded  with sulforhodamine 101 acid chloride 
(Texas Red) (type I) and flouresceine isothiocyanante (FITC) excitation filters (type IIa). 
Approximately 100-300 total fibers were manually counted and relative proportions were 
calculated.  
Quantification of intramuscular lipid metabolite diacylglycerols (DAG) and ceramides 
(Cer) were performed using high-performance liquid chromatography tandem mass spectrometry 
(101) at the Lipidomics Core, Medical University of South Carolina. This allows quantitative 
analysis of different species of DAG and Cer.  Tissue homogenates (in buffer containing 0.25 M 
sucrose, 25 nM KCl, 50 nM Tris, 0.5 mM EDTA, pH 7.4) were fortified with internal standards 
and extracted into a one-phase neutral organic solvent system (ethyl acetate/isopropyl 
alcohol/water; 60:30:10 v/v/v), evaporated and reconstituted in methanol and analyzed by a 
surveyor/TSQ 7000 liquid chromatography/mass spectrometry system (Thermo Finigan,  
Thermo Fisher Scientific Inc., Waltham, MA) (102). Quantitative analysis was performed in a 
positive multiple-reaction monitoring mode, based on calibration curves generated by adding to 
an artificial matrix known amounts of target analytes, synthetic standards, and an equal amount 
of internal standard. The DAG and Cer levels were normalized to total protein levels (1mg of 
protein/sample).   
3.2.3.7 Magnetic resonance spectroscopy (1H-MRS)(visit 3) 
The two newly recruited groups (older normal weight sedentary and older athletes) underwent 
1H-MRS to measure intra-myocellular lipid (IMCL). Scanning was performed on the  3.0T 
scanner (Siemens 3T Trio, Siemens Medical Systems, Erlanger, Germany) at the University of 
Pittsburgh Magnetic Resonance Research Center (MRRC) located on the 8th floor of the 
Presbyterian hospital.  
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IMCL was measured using the extremity coil. The inferior extremity of patella served as 
landmark for the placement of the coil. IMCL concentration levels were measured in a single 
11x12x18 mm3 Voxel placed in the right tibialis anterior in a position such as to limit as much 
as possible visible interstitial tissue or fat (figure 4).  
 
 
 
Figure 4 Example of voxel placement in the tibialis anterior (Siemens 3Tesla, PRESS TR3s TE 30 ms 
11x12x18mm3, extremity coil) 
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The acquisition used an optimized PRESS sequence (repetition time = 3 s, echo time = 20 
ms, 128 acquisitions, water presaturation) (53, 103). To assess the quality of the acquisition, the 
following criteria were used (figure 5): 1) the splitting of resonances of creatine CH2 at 3.96 ppm 
(Cr2, peaks 14 and 15) (104), 2) presence of trimethylammonium (TMA, peak 12) and of the 
central peak of creatine CH3 (peak 10), 3) the separation of EMCL-CH2 and IMCL-CH2 
(respectively peaks 4 and 3) (105).  
 
 
 
Figure 5 1H-MRS Spectrum of a single voxel in the muscle tibialis anterior (Siemens 3Tesla, PRESS 
TR3s TE 30 ms 11x12x18mm3, extremity coil) 
 
After phasing and referencing the raw spectra (to the water peak at 4.7 ppm), IMCL was 
quantified by using the unsuppressed water signal as internal concentration standard. Fitting of 
the spectra was done with jMRUI software version 2.2 (http://www.mrui.uab.es/mrui/), using 
published prior knowledge (106) calibrated via the unsuppressed water signal.  To assess the 
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quality of the fit, the following criteria were used 1) the smallest residues possible and 2) the 
width of the IMCL-CH2.  
Absolute IMCL levels in millimoles per kilogram muscle wet weight were calculated 
using the area of the IMCL resonance, the area of H2O resonance and a correction factor based 
on the concentration of water in the muscle, the correction for different voxel sensitivity, the 
correction for relaxation, the number of resonating protons as described in table 4.  
 
 
Table 4 Numbers used for the determination of absolute concentrations of IMCL 
Concentration of H2O muscle     
MR Visibility (106) 76% [%] 
Density of tissue [wet weight] (106) 1.06 [g/ml] 
Density of H2O muscle 1 [g/ml] 
Molecular weight of H2O muscle 18 [g/mol] 
Concentration of H2O muscle 39832 [mmol/kg ww] 
   
Correction for different voxel sensitivity     
Sensitivity in H2O voxel 1 [au] 
Sensitivity in IMCL voxel 1 [au] 
Correction factor for H2O/IMCL sensitivity 1   
   
Correction for relaxation and number of resonating protons     
Number of protons of resonating in H2O signal 2   
Number of protons of resonating in IMCL signal 62   
Repetition time TR 2000 [msec] 
Echo time TE 30 [msec] 
Relaxation time T1 of H2O signal(107) 900 [msec] 
Relaxation time T2 of H2O signal(107) 29 [msec] 
Relaxation time T1 of IMCL signal(107) 382 [msec] 
Relaxation time T2 of IMCL signal(107) 68 [msec] 
Correction factor for H2O decay/saturation 0.317   
Correction factor for IMCL decay/saturation 0.640   
Correction factor for relaxation and number of protons 0.016   
   
Overall correction factor 636 [mmol/kg ww] 
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3.2.3.8 Magnetic resonance imaging (MRI) or Computed Tomography (CT) (visit 3) 
The two newly recruited groups (older normal weight sedentary and older athletes) underwent 
MRI to measure visceral adipose tissue (VAT). Scanning was performed during the same MR 
session than the 1H-MRS at the University of Pittsburgh Magnetic Resonance Research Center 
(MRRC). The two groups recruited in the prior years (older obese sedentary and middle age 
normal weight sedentary) had their imaging performed with CT. These scans were preformed 
with a GE Hi-speed multiple slice scanner (GE Healthcare, Waukesha, WI, USA) at Center 
Commons MRI and CT office offsite in Shadyside.  
For the MRI, VAT and total abdominal fat were measured from a single slice abdominal 
T1-weighted image at the L3-L4 level acquired during a breath hold. MIPAV version 1.2 
(Medical Image Processing, Analysis and Visualization, Center for Information Technology, 
National Institute of Health, Bethesda, MD) was used to analyze the central slice. First the 
different perimeters (whole abdomen, visceral area) were drawn and the surfaces were recorded. 
Then the solid organs (liver and kidneys) were removed if present on the slice of interest. To 
separate adipose tissue from lean tissue, an automated fuzzy c means algorithm (figure 6) was 
used in conjunction to inhomogeneities corrections (108, 109).  
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Figure 6 Example of Fuzzy C means algorithm for Abdominal MRI analysis (Siemens 3T, body coil, 
TR 34ms, TE 3.69ms, slice thickness 10 mm)  
 
 
This automated pixel clustering algorithm identified light and dark pixels by comparing 
pixel intensities defined by a specified number of classes. We used two classes: adipose tissue 
(light pixels) and muscle (dark pixels). This approach removed subjectivity and enhanced 
reproducibility (110).  
The CT images were analyzed using SliceOmatic software version 3 (Tomovision, 
Montreal, QC, Canada). Adipose tissue was measured by selecting the regions of interest as 
defined by Hounsfield Units of attenuation (HU) which are based on a linear attenuation 
coefficient scale using water as a reference (0 HU), thus allowing a quantitative scale for 
radiodensity (111).  
Due to the difference of technique, the following ratios were computed to compare CT 
and MR data: visceral adipose tissue/total abdominal adipose tissue (VAT/TAAT) and 
subcutaneaous abdominal adipose tissue/total abdominal adipose tissue (ScAAT/TAAT).  
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3.3 DATA ANALYSIS 
3.3.1 Data Collection, management and quality control 
After all of the analysis (histology, Mass spectroscopy), readings (MRI), post-processing (MRS) 
and computations (stable isotopes and clamps) were performed, all data was entered in a main 
database and de-identified to protect subject identity. Data management and quality control were 
thoroughly performed by comparing results of the different measures to literature results or when 
not available (1H-MRS) by discussing the methods and results with experts in the field.  
3.3.2 Descriptive and exploratory analysis 
Frequencies and percentages were used to summarize the dichotomous and categorical variables. 
Continuous variables were summarized by the mean, standard error of the mean, minimum and 
maximum values. The distributions of each key variables were examined for differences, to 
identify outliers and to determine whether transformation were required. The distributions were 
viewed using histograms for general shape and skewness. Boxplots were used to identify 
outliers. Bivariate correlations and scatterplots were also examined.  
3.3.3 Statistical analysis Specific Aim 1: To examine the effects of older age on 
insulin resistance in sedentary subjects 
This aim compared normal weight sedentary older subjects vs. normal weight sedentary younger 
subjects in their insulin sensitivity. It was hypothesized that the older normal weight sedentary 
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subjects would be more insulin resistant, i.e., have lower insulin sensitivity than younger normal 
weight sedentary subjects.  
The main analysis for this aim was based on an independent t test with rate of glucose 
disposal (Rd) as the dependent variable of insulin sensitivity and group as the independent 
variable.  
Other group differences were also studied with independent t test. These included 
subjects’ characteristics (i.e. age, weight, BMI, systolic and diastolic blood pressure), blood 
results (lipid panel, fasting glucose), body composition data (i.e. FFM, FM, fat%), VO2peak, 
HGO, REE and the abdominal imaging ratios (i.e VAT/TAAT and ScAAT/TAAT). If the 
assumption of equal variances (Bartlett test) were not met, comparisons between groups for these 
specific variables were performed using the Welch ANOVA for the means test, which is 
equivalent to an unequal variance t test. Although this test is robust for non-normality, if the 
assumption of normality (Shapiro-Wilk test) was not met, the results of the Welch test were 
compared to the non parametric Median test.  
3.3.4 Statistical analysis Specific Aim 2: To examine the effects of obesity on 
insulin resistance and intramyocellular lipids in sedentary older subjects   
This aim compared insulin sensitivity and IMCL content in normal weight sedentary older 
subjects vs. obese sedentary older subjects. It was hypothesized that the obese subjects would be 
more insulin resistant compared to normal weight subjects matched by age and physical activity. 
It was also hypothesized that the lower skeletal muscle insulin sensitivity in the obese subjects 
would be observed in the context of higher IMCL, including IMTG, DAG and Cer.  
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The main analysis for the first hypothesis of this aim was based on an independent t test 
with Rate of glucose disposal (Rd) as the dependent variable and group as the independent 
variable. Other group differences were also studied with independent t test. These included 
subjects’ characteristics (i.e. age, weight, BMI, systolic and diastolic blood pressure), blood 
results (lipid panel, fasting glucose, HbA1c), body composition data (i.e. FFM, FM, fat%), 
VO2peak, HGO, REE, fat- and cho-ox and the abdominal imaging ratios (i.e VAT/TAAT and 
ScAAT/TAAT). If the assumption of equal variances (Bartlett test) were not met, comparisons 
between groups for these specific variables were performed using the Welch ANOVA for the 
means test, which is equivalent to an unequal variance t test. Although this test is robust for non 
normality, if the assumption of normality (Shapiro-Wilk test) was not met, the results of the 
Welch test were compared to the non parametric Median test. In addition, to look at the possible 
covariance effect of VAT, an analysis of covariance on Rd x group was performed with VAT as 
the covariable and another one with VAT/TAAT as the covariable.  
For categorical dependent variables such as gender, metabolic status (normal glucose 
tolerance vs. impaired glucose tolerance) and impaired fasting glucose vs. normal fasting 
glucose, contingency analyses with the Pearson Chi-square test were was performed to assess for 
differences of proportions between the two groups.  
As REE, Fat-ox and Cho-ox were assessed in the fasting condition and at the end of the 
glucose clamp, the switch from the fasting to the insulin-stimulated condition for each of these 
variables was assessed with one tail paired t test for each group and with a 2x2 repeated 
measures ANOVA (group x time).  
For the second hypothesis of this aim, we performed separate independent t tests to 
compare IMTG, total DAG and Cer between the two groups. Other group differences were also 
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studied with independent t test. These included percentage of fiber types, SDH, and the different 
species of DAG and Cer. The assumptions were checked as described above and the same 
statistical tests were preformed if the assumptions were not met.  
3.3.5 Statistical analysis Specific Aim 3:  To examine the effects of chronic exercise 
on insulin resistance and IMCL in older subjects 
This aim compared insulin sensitivity and IMCL content in older endurance trained Masters 
athletes vs. normal weight sedentary older subjects. It was hypothesized that the athletes would 
have greater insulin sensitivity compared to sedentary subjects matched by age and total body 
fatness. It was also hypothesized that the higher skeletal muscle insulin sensitivity in the athletes 
would be observed in the context of higher IMTG content but with lower levels of  DAG and 
Cer.  
The main analysis for the first hypothesis of this aim was based on an independent t test 
with Rate of glucose disposal (Rd) as the dependent variable and group as the independent 
variable. Other group differences were also studied with independent t test. These included 
subjects’ characteristics (i.e. age, weight, BMI, systolic and diastolic blood pressure), blood 
results (lipid panel, fasting glucose, HbA1c), body composition data (i.e. FFM, FM, fat%), 
VO2peak, HGO, REE, fat- and cho-ox, VAT  and the abdominal imaging ratios (i.e VAT/TAAT 
and ScAAT/TAAT). The assumptions were checked as described for the second specific aim and 
the same statistical tests were preformed if the assumptions were not met. In addition, to look at 
the possible covariance effect of body fatness, an analysis of covariance on Rd x group was 
performed with fat mass as the covariable and another one with percent body fat as covariable. 
As described for the specific aim 1, the categorical variables (gender, metabolic status, fasting 
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glucose status) were analyzed with contingency tables. In addition, the switch from fasting to 
insulin-stimulated condition (REE, Fat-ox, Cho-ox) was assessed by paired t test and 2x2 mixed 
ANOVA as described for the specific aim 2.  
For the second hypothesis of this aim, we performed separate independent t tests to 
compare IMCL measured by 1H-MRS, IMTG measured by ORO staining, total DAG and Cer 
between the 2 groups. Other group differences were also studied with independent t test. These 
included percentage of fiber types, SDH, and the different species of DAG and Cer. As for the 
previous analyses, the assumptions were checked as described above and the same statistical 
tests were preformed if the assumptions were not met.  
3.3.6 Secondary analyses – Differences in insulin sensitivity and intramyocellular 
lipids among older athletes, normal weight and obese sedentary subjects.  
Differences in Rd between the three older groups (athletes, normal weight sedentary and obese 
sedentary subjects) were performed with a one-way between subjects ANOVA with post hoc 
analysis (Tukey HSD adjustment).  
 To examine patterns of differences of the molecular species of DAG and Cer, one-way 
between subjects ANOVAs were performed for each molecular species. This allowed us to 
combine species in three primary sub-groups: “group I” were the species found significantly 
higher in the obese group, “group II” were the species found to be significantly higher in the 
athletes and “group III” were not significant or neither higher in the obese nor in the athletes.  
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3.3.7 Statistical tools 
The descriptive and exploratory examination was performed using JMP for Macintosh version 
5.2.1.2 (SAS Institute Inc., Cary, NC), which allows the identification of each point in the 
scaterplots and histograms. Parametric tests and covariates analysis were also performed with 
JMP. The non-parametric tests and transformations were performed using Stata for Macintosh 
version 10.0 (StataCorp, College Station, TX). Analyses of covariance (ANCOVA) were 
performed using manually entered syntax with SPSS for Macintosh version 16.0.2 (SPSS inc. 
Chicago, IL). 
For all analyses, the α level was set a priori at 0.05. All statistics were carried out in a 2-
tailed manner. 
3.3.8 Sample size and Power calculations 
All the aims in this study included the primary dependent variable of insulin sensitivity. Based 
on previous studies we were able to estimate sample sizes for the specific aims 2 and 3. It is 
important to note that our focus was on the recruitment needs for the two newly recruited subject 
groups: sedentary normal weight older subjects and older athletes.  
For the second comparison, sedentary normal weight older subjects vs. sedentary obese 
older subjects, we based our power calculations on results of a former published study of Dr. 
Goodpaster (85) comparing young sedentary obese subjects (N=32, mean Rd 5.87, SD 3.11 
mg/min/kgFFM) to young sedentary lean subjects (N=15, mean Rd 9.39, SD 2.75 mg/min/kgFFM). 
Based on a paired t test with a two-sided significance level set at P=0.05, with a power of 0.80, 
we estimated that we needed to recruit 9 subjects in both groups. With an estimation of 25% 
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drop-out rate during the measurement period, we projected to recruit 11 subjects for the 
sedentary normal weight older group. The sedentary obese older subjects were matched as 
described in chapter 3.1.2.3. These calculations were only based on insulin sensitivity measures.  
For the third comparison, sedentary normal weight older subjects vs. Masters athletes, we 
based our power calculations on results of a former published study (112) comparing young 
sedentary normal weight subjects (N=13, whole body insulin sensitivity index 5.49, SD 2.46) to 
young athletes (N=23, whole body insulin sensitivity index 9.77, SD 3.87). Based on a paired t 
test with a two-sided significance level set at P=0.05 and a power of 0.80, we estimated the need 
to recruit 7 subjects in both groups. With an estimation of 25% drop-out rate during the 
measurement period, we anticipated to recruit 9 subjects for the master athletes. These 
calculations were only based on insulin sensitivity measures. 
 For the first comparison, sedentary normal weight older subjects vs. sedentary normal 
weight younger subjects, we decided to use the sample size estimated for the specific aim 2 (see 
above) and match the number of subjects with an equivalent number of the sedentary normal 
weight younger subjects (see chapter 3.1.2.2).  
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4 RESULTS 
4.1 RECRUITMENT 
As described in chapter 3.1.2.1., I specifically recruited the older normal weight sedentary 
subjects and the athletes for this project.  Figure 7 presents the exact numbers and exclusion 
reasons for the older normal weight sedentary subjects. It is important to note that in order to 
maintain gender balance in this group, recruitment was stopped earlier for women.  
 
Figure 7 Recruitment flow chart for the older normal weight sedentary subjects 
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Figure 8 presents the exact numbers and exclusion reasons for the athletes. In order to maintain 
gender balance across comparison groups, potential male athletes responding to recruitment ads 
were not enrolled for the last 6 months of the recruitment period.   
 
 
Figure 8 Recruitment flow chart for the athletes 
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4.2 RESULTS FOR SPECIFIC AIM 1: TO EXAMINE THE EFFECTS OF OLDER 
AGE ON INSULIN RESISTANCE IN SEDENTARY SUBJECTS 
4.2.1 Subjects  
A total of seven (4 women and 3 men) older normal weight sedentary subjects were enrolled and 
completed the testing procedure. Seven younger normal weight sedentary subjects were selected 
among data from Dr. Goodpaster’s earlier study matched on gender and BMI to the older group 
as described in chapter 3.1.2.2. The characteristics for these two groups are presented in table 5.  
 
Table 5 Specific aim 1 - Subject characteristics 
 
 
The older and younger groups did not differ with respect to physical fitness, fasting 
glucose and insulin or lipid profile (table 6). On average both groups had a normal fasting 
glucose, although two subjects in each group were identified as having impaired fasting glucose 
(fasting glucose > 100 mg/dl), and one subject in the older group had impaired glucose tolerance 
(see chapter 3.2.3.1). The older subjects had on average more body fat than the younger subjects. 
Abdominal fat distribution was similar between the two groups. Interestingly, the fat free mass 
was not significantly different between the two groups. The younger subjects had higher resting 
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energy expenditure values than the older subjects, but this was not significantly different when 
expressed relative to fat free mass.  Systolic blood pressure was elevated in the older compared 
to the younger, but diastolic blood pressure was similar.  
 
Table 6 Specific aim 1 - Physical fitness, body composition, blood pressure, fasting glucose and 
insulin, lipid panel, resting energy expenditure and abdominal fat distribution 
 
4.2.2 Insulin sensitivity 
Insulin sensitivity was not different between the older and the younger normal weight sedentary 
subjects (figure 9). It is important to note that one subject from the older group was identified as 
a possible outlier (far outside the upper whisker of the boxplot) with an Rd of 14.29 
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ml/min/kgFFM, The range of Rd for the other subjects in the older normal weight sedentary group 
was from 4.62 to 9.84 ml/min/kgFFM,  and for the younger normal weight sedentary group Rd 
ranged going from 5.7 to 9.59 ml/min/kgFFM.. The outlier was confirmed by a Grubbs outlier test 
(P<0.05).  All of the analyses revealed that the results were similar with or without this outlier 
(for all the specific aims). Therefore, this data point was maintained in the dataset. To illustrate 
how this data point influences the mean of the older group, figure 6 presents the comparison with 
and without this outlier.  
 
 
Figure 9 Specific aim 1 - Insulin sensitivity (Rd = rate of glucose disposal, FFM = fat free mass) 
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4.3 RESULTS FOR SPECIFIC AIM 2: TO EXAMINE THE EFFECTS OF OBESITY 
ON INSULIN RESISTANCE AND INTRAMYOCELLUYLAR LIPIDS (IMCL) IN 
SEDENTARY OLDER SUBJECTS 
4.3.1 Subjects  
The same group of seven (4 women and 3 men) older normal weight sedentary subjects was used 
for this comparison (‘Normal weight’). Fourteen older obese sedentary (‘Obese’) subjects were 
selected among the baseline data available from the SHELL and the MIRA studies as described 
in chapter 3.1.2.3. The subject characteristics for these two groups are presented in table 7.  
 
Table 7 Specific aim 2 - Subject characteristics 
 
 
There were no differences in peak oxygen uptake between the two groups when the data 
were expressed in absolute values (L/min) (table 8). However, when expressed to more 
physiologically relevant values relative to FFM to account for the muscle mass, normal weight 
subjects had on average a higher oxygen uptake than the obese subjects (P=0.012). Neither the 
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peak work output nor the total time of the test were statistically different between the two 
groups: 138.6 ± 22.3 Watts and 9.37 ± 1.3 minutes for the normal weight group, 102.2 ± 8.1 
Watts and 7.31 ± 0.6 minutes for the obese group (P=0.17 and 0.11 respectively).  Peak heart rate 
tended to be higher in the normal weight group (160.6 ± 5.9 bpm) compared to the obese group 
(147.3 ± 3.6 bpm, P=0.057). 
 
Table 8 Specific aim 2 - Physical fitness, body composition, blood pressure, blood labs and abdominal 
fat distribution 
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Body composition and fat distribution were significantly different between the two 
groups, the obese having more fat mass and greater abdominal fat than the normal weight 
subjects (table 8). Fasting glucose, fasting insulin or lipid profile also differed significantly 
between the two groups, towards a less metabolically favorable profile in the obese group. 
4.3.2 Insulin sensitivity 
The normal weight group had a higher rate of insulin-stimulated glucose disposal (Rd) than the 
obese group (figure 10). This difference remained after adjusting for VAT and of VAT/TAAT as 
potential covariates. When examining the two components that account for insulin-stimulated 
glucose disposal, the difference in Rd was explained by a higher capacity for glucose storage 
(P=0.006) in the normal weight subjects, but not in glucose oxidation (P=0.43).  
 
 
Figure 10 Specific aim 2 - Insulin sensitivity (Rd = rate of glucose disposal, FFM = fat free mass) 
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Hepatic insulin sensitivity can be expressed as insulin-stimulated hepatic glucose output 
(HGO), or as percent of HGO suppression by insulin. As presented in figure 11, the obese 
subjects had significantly lower HGO suppression than the normal weight subjects, indicating 
their lower hepatic insulin sensitivity.  
 
 
Figure 11 Specific aim 2 - Hepatic glucose output  (HGO) 
 
4.3.3 Systemic substrate oxidation and energy expenditure 
The obese group had on average a higher REE (1634.5 ± 128.3 kcal/24h) than the normal weight 
group (1271.9 ± 74.7 kcal/24h, P=0.022) (figure 12). This difference disappeared when REE was 
normalized for FFM. There were no significant differences in RQ, CHO-ox or Fat-ox in fasting 
or in insulin-stimulated conditions either in absolute (figure 12) or relative units (table 9) 
between normal weight and obese groups..  
   
 57 
Table 9 Specific aim 2 - Substrate oxidation and energy expenditure 
 
 
Both normal weight and obese subjects increased their CHO-ox and decreased their Fat-
ox significantly when going from fasting to insulin-stimulated conditions, without differences 
between groups  (Paired t test P<0.001, significant effect of time P<0.001) (figure 12). Only the 
normal weight group increased significantly their total energy expenditure in response to insulin 
(Paired t test P<0.05 and a trend towards interaction effect P=0.06 for REE/FFM and P=0.07 for 
REE).  
 
Figure 12 Specific aim 2 - Metabolic flexibility 
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4.3.4 Intramyocellular lipids  
Surprisingly, we did not observe, as hypothesized, a higher content of IMTG measured with 
histologic ORO staining in the obese group compared to the normal weight group (figure 13). To 
the contrary, the total amount of IMTG tended to be lower in the obese subjects.  
 
 
Figure 13 Specific aim 2 - Intramyocellular triglycerides (IMTG) 
 
 
Differences between groups in total Cer and total DAG are depicted in figure 14. Obese 
subjects had significantly higher total Cer than normal weight subjects. No differences were 
found in DAG.  
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Figure 14  Specific aim 2 -  Total ceramides (Cer, panel A) and total diacylglycerols (DAG, panel B) 
 
The concentrations of the various species of Cer and other sphingolipids are presented in 
table 10. The majority of sphingolipids (18:1, 24:0, 24:1, Sphingosine-1P) were significantly 
higher in the obese group, while 14:0 Cer and Sphingosine were higher in the normal weight 
group.  
 
Table 10 Specific aim 2 - Ceramides 
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The concentrations of the different species of DAG are presented in table 11. Some 
species of DAG (16:1/18:1, DiC 14:0, DiC 18:1) were significantly higher in the obese group, 
while others (14:0/18:0, 16:0/18:0. DiC18:0) were higher in the normal weight group.  
 
Table 11 Specific aim 2 - Diacylglycerols 
 
 
 
The oxidative capacity of muscle and the proportion of the more oxidative type I fibers 
are potential covariates to explain differences in intramyocellular lipids and insulin resistance. 
We did not observe any significant differences in the proportion of type I fibers or in oxidative 
capacity assessed by succinate dehydrogenase (SDH) staining in these two groups (figure 15).   
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Figure 15 Specific aim 2 - Proportion of fiber type I (panel A) and oxidative capacity (SDH, panel B) 
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4.4 RESULTS FOR SPECIFIC AIM 3: TO EXAMINE THE EFFECTS OF CHRONIC 
EXERCISE ON INSULIN RESISTANCE AND IMCL IN OLDER SUBJECTS 
4.4.1 Subjects 
A total of fourteen (4 women and 10 men) Masters athletes (‘Athletes’) were enrolled and 
completed the testing procedures. The same group of seven (4 women and 3 men) older normal 
weight sedentary subjects (‘Normal weight’) described above was used for this comparison. 
Table 12 presents the subject characteristics for these two groups. These groups were similar age, 
weight and BMI. 
 
Table 12 Specific aim 3 - Subject characteristics 
 
 
The athletes had higher peak aerobic capacity (table 13) than the normal weight sedentary 
subjects. The peak work output was higher in the athletes (205.1 ± 15.6 vs. 138.6 ± 22.3 Watts, 
P=0.02). Peak heart rate was above age-predicted and was similar in both groups (161.4 ± 3.4 
bpm vs. 160.6 ± 5.9 bpm, P=0.90) indicating that both groups gave a similar maximal voluntary 
effort.  
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Body composition and fat distribution (table 13) were significantly different between the 
two groups, the athletes having less fat mass, less overall abdominal fat and less subcutaneous 
abdominal fast than the normal weight sedentary subjects. Regarding visceral abdominal fat 
(VAT), one outlier was identified in the athlete group, but no significant difference was observed 
with or without this outlier, therefore the data was kept in the comparison. FFM tended to be 
higher in the athletes compared to their sedentary counterparts. Fasting glucose, fasting insulin or 
lipid profile did not differ between the two groups. 
 
Table 13 Specific aim 3 - Physical fitness, body composition, blood pressure, blood labs and 
abdominal fat distribution 
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4.4.2 Insulin sensitivity 
The athletes had a higher rate of insulin-stimulated glucose disposal (Rd) than the normal 
weight group (figure 16). This difference remained after taking into account the amount and 
proportion of body fat as potential covariates. The higher Rd in athletes was explained by a 
higher capacity for non-oxidative glucose disposal, or glucose storage (P=0.002), but not by 
insulin-stimulated glucose oxidation (P=0.91). Liver insulin sensitivity assessed by insulin-
stimulated hepatic glucose output (HGO) was similar in both groups (figure 17).  
 
 
 
Figure 16 Specific aim 3 - Insulin sensitivity (Rd = rate of glucose disposal, FFM = fat free mass) 
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Figure 17 Specific aim 3 - Hepatic glucose output (HGO) 
4.4.3 Systemic substrate oxidation and energy expenditure 
The athletes had on average a higher REE (1456.9 ± 45.3 kcal/24h) than the normal weight 
group (1271.9 ± 74.7 kcal/24h, P=0.04) (figure 18), but this difference disappeared when 
adjusting for FFM. In the fasting condition, absolute rates for Fat-ox was higher in the athletes 
compared to the normal weight subjects (1080.5 ± 95.8 vs. 785.3 ± 50.1 kcal/24h respectively, 
P=0.01), but these differences also disappeared when normalized for FFM (table 14). There were 
no significant differences between the two groups in what regards RQ and CHO-ox in fasting 
condition in either absolute (figure 18) or relative (to FFM) units (table 14).  
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Table 14 Specific aim 3 - Substrate oxidation and energy expenditure 
 
 
When switching from the fasting to the insulin-stimulated condition, both groups 
increased their REE and CHO-ox and decreased their Fat-ox significantly (Paired t tests P<0.05, 
figure 18). The magnitude of this change in substrate selection was significantly greater in the 
athlete group (significant interaction effect for Fat-ox P=0.01 and for CHO-ox P=0.03).  
 
 
 
Figure 18 Specific aim 3 - Metabolic flexibility 
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4.4.4 Intramyocellular lipids  
The athletes tended to have a higher content of IMTG in the vastus lateralis measured 
with the ORO staining compared to the normal weight group (figure 19). These results obtained 
with the ex-vivo invasive method were concordant with the results obtained from the in-vivo 
non-invasive method in the tibialis anterior with 1H-MRS (figure 20), which show that IMCL 
was also higher in the athletes compared to the normal weight sedentary subjects.  
 
 
Figure 19 Specific aim 3 - Intramyocellular triglycerides (IMTG) by ORO staining 
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Figure 20 Specific aim 3 - Intramyocellular lipids (IMCL) by 1H-MRS relative to the water 
content (panel A) and in absolute concentrations (panel B). (TA = tibialis anterior, WW = wet 
weight). The test-retest reliability for the measure of IMCL via 1H-MRS was acceptable with an r= 0.932, 
P=0.011 (N=5) 
 
 
Differences in total Cer and total DAG within skeletal muscle vastus lateralis biopsy 
specimens are depicted in figure 21.  No significant differences were observed between the 
athletes and the normal weight sedentary subjects. The concentrations of the different species of 
Cer and other sphingolipids are presented in table 15. Only Sphingosine-1P tended to be higher 
in the athletes than in the normal weight subjects.  
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Figure 21 Specific aim 3 -  Total ceramides (Cer, panel A) and total diacylglycerols (DAG, panel B) 
 
Table 15 Specific aim 3 - Ceramides 
 
 
The concentrations of the different species of DAG are presented in table 16. DAG 
species of 14:0/18:0, 16:0/18:1, 16:1/18:1, 18:0/18:1, DiC 16:0 were significantly higher in the 
athletes group. We did not find any species that were significantly higher in the normal weight 
group.  
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Table 16 Specific aim 3 - Diacylglycerols 
 
 
The oxidative capacity of muscle and the proportion of the more oxidative type I fibers 
are potential covariates to explain differences in intramyocellular lipids and insulin resistance. 
We observed significant differences in the proportion of type I fibers or in oxidative capacity 
assessed by succinate dehydrogenase (SDH) staining in these two groups (figure 22).   
 
Figure 22 Specific aim 3 - Proportion of fiber type I (panel A) and oxidative capacity (SDH, panel B) 
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4.5 DIFFERENCES IN INSULIN SENSITIVITY AND INTRAMYOCELLULAR 
LIPIDS AMONG OLDER ATHLETES, NORMAL WEIGHT AND OBESE SEDENTARY 
SUBJECTS 
To gain a better perspective on differences in insulin sensitivity and intramyocellular lipids 
according to obesity and chronic physical activity among older adults, additional three-group 
analyses were performed. Differences in Rd among the three older groups matched by age 
(Masters athletes, normal weight and obese sedentary) are presented in figure 23. Athletes were 
more insulin sensitive than normal weight sedentary subjects, who in turn were more insulin 
sensitive than obese sedentary subjects. Athletes did not, however, have higher hepatic insulin 
sensitivity (HGO suppression) than normal weight sedentary subjects, although both of these 
groups had higher HGO suppression than obese subjects. 
 
 
Figure 23 Three older groups comparison - insulin sensitivity (A, B, and C = significant statistical 
differences in the one-way between subjects ANOVA, Rd = rate of glucose disposal, FFM = fat free mass, HGP = 
hepatic glucose production)  
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IMTG, oxidative capacity and the proportion of type I fibers measured by histochemistry 
are presented in figure 24. Athletes had higher IMTG than obese subjects. Athletes also had 
higher oxidative capacity measured by SDH staining compared to both normal weight and obese 
subjects, and normal weight subjects had higher oxidative capacity than obese subjects. Athletes 
had higher proportion of type I fibers than both the normal weight and the obese sedentary 
groups.  
 
 
Figure 24 Three groups comparison – IMTG, oxidative capacity and proportion of type I fibers  (A, 
B, and C = significant statistical differences in the one-way between subjects ANOVA, IMTG = intramyocellular 
triglycerides, SDH = succinate deshydrogenase)  
 
Total Cer were significantly higher in the obese than in the two other groups (figure 25, 
panel A).  Total DAG were significantly higher in the athletes compared to the obese, but did not 
reach significance compared to the normal weight subjects (figure 25, panel B). Bivariate 
correlations showed that Rd was negatively associated with the total content of Cer (R2=0.23, 
P=0.03) but positively associated with DAG (R2=0.22, P=0.03).  
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Figure 25 Three groups comparison - Total ceramides (Cer, panel A) and total diacylglycerols (DAG, 
panel B) (A, B, and C = significant statistical differences in the one-way between subjects ANOVA) 
 
 
To examine possible patterns of lipid species distribution across the three subject groups, 
one-way ANOVAs were performed for each molecular species of Cer and DAG. Based on the 
results of these tests, we separated the species in three groups (table 17). Those species that were 
significantly higher in the athletes were put together in a group that was labeled “Group I”. 
Those that were significantly higher in the obese subjects were put together in a group labeled 
“Group II”. Those that were neither higher in the athletes nor in the obese were labeled “Group 
III”.  
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Table 17 Three groups comparison – DAG and Cer species 
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5 DISCUSSION 
5.1  EFFECTS OF OLDER AGE ON INSULIN RESISTANCE IN SEDENTARY 
SUBJECTS 
The first specific aim was to determine whether or not older age is associated with insulin 
resistance independently of obesity and of chronic exercise. We hypothesized that normal weight 
younger subjects would be more insulin sensitive than normal weight older subjects, when 
matched by BMI and by physical activity level (all sedentary subjects). 
The key finding of the first specific aim was that insulin sensitivity was not different in 
older normal weight sedentary subjects compared to younger normal weight sedentary subjects.  
Although our sample size was limited to adults from middle-age to those in their 70’s, this is an 
important argument supporting that insulin resistance may not be characteristic of aging per se.  
 We recently reported that, similar to observed for normal weight subjects, insulin 
sensitivity is also similar in sedentary obese older vs. obese younger adults (Amati, Diabetes 
Care, in press). Our results are consistent with former studies comparing younger and older 
normal weight individuals with sedentary lifestyles (113), but are in contrast with other studies 
not controlling for patterns of physical activity (6, 63, 114).  
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5.2 EFFECTS OF OBESITY ON INSULIN RESISTANCE AND 
INTRAMYOCELLULAR LIPIDS IN SEDENTARY OLDER SUBJECTS 
The primary purpose of the second specific aim was to determine whether or not obesity or 
generalized adiposity is associated with insulin resistance independently of physical activity 
specifically within older subjects. We first hypothesized that sedentary obese subjects would 
have lower insulin sensitivity compared to age matched sedentary normal weight subjects. 
A primary finding was that obesity was associated with lower insulin sensitivity (thus a 
greater insulin resistance) in sedentary older adults. Furthermore, the effect of obesity on insulin 
sensitivity was independent of visceral adiposity. This was true not only for overall insulin 
sensitivity but also for hepatic insulin sensitivity as the obese subjects had an incomplete glucose 
output suppression compared to their normal weight counterparts. Thus after accounting for both 
age and level of chronic physical activity, obesity per se was associated with insulin resistance in 
sedentary subjects. These results are in accord with a number of studies demonstrating an effect 
of obesity (10, 115) and weight loss (85, 116) on insulin sensitivity in younger adults. Although 
there are fewer studies examining insulin resistance specifically in older adults, our results also 
confirm that obesity but not aging is primarily associated with insulin resistance.  
We also examined markers of metabolic flexibility, corresponding to the ability to switch 
from mostly fat oxidation in the fasting condition to carbohydrate oxidation in the insulin-
stimulated condition. We found that obese subjects were no less metabolically flexible than 
normal weight older adults, as both groups increased their reliance on carbohydrates and 
decreased their reliance on fat going from the fasted to the insulin-stimulated condition. This is 
in apparent contrast to the seminal work by Kelley and colleagues (10) who reported that fat 
oxidation after an overnight fast was impaired in obesity. However, in that study, metabolic 
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flexibility was assessed more specifically in skeletal muscle using limb balance methods to 
examine substrate metabolism in skeletal muscle. The current study relied on whole body 
measurements of substrate oxidation, which could explain the discrepancy due to the fact other 
tissues and organs are also taken into account in the current study. Therefore, the possibility 
remains that skeletal muscle fatty acid oxidation during fasting conditions is indeed impaired in 
these obese older subjects.  
We also hypothesized that lower skeletal muscle insulin sensitivity in sedentary obese 
older subjects would be observed in the context of higher intramyocellular triglycerides (IMTG) 
and with higher levels of potentially harmful lipid metabolites, including diacylglycerols and 
ceramides, compared to sedentary normal weight older subjects. Surprisingly, we did not find 
higher IMTG in the obese insulin resistant group as described in previous studies with younger 
subjects (44). It is important to note that none of our subjects had type 2 diabetes. This is further 
evidence supporting the notion that it may not be IMTG per se that directly confers insulin 
resistance.  
An important finding of this study was that obese older subjects had nearly two-fold 
higher ceramide levels within muscle compared to either athletes or normal weight sedentary 
subjects. These results agree with a study by Adams et al (20) who found higher ceramide 
content in skeletal muscle of obese younger subjects. Straczkowski et al (117) also found the 
inverse relationship between ceramide content and insulin sensitivity. Bruce et al (118) found 
that eight weeks of training tended to reduce both the total ceramide content and the saturated 
ceramide species in young obese insulin-resistant subjects without significant weight loss.  
We observed that total diacylglycerol content within muscle was not significantly 
different between obese and normal weight groups. Contrary to what we hypothesized, we did 
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not observe an association between the total content of diacylglycerols (DAG) and either obesity 
or with insulin resistance. This is in contradiction with animal studies (119) as well as human 
studies with lipid infusion showing the relationship between DAG content and insulin resistance 
(19). However, Straczkowski et al (117) did not find increased levels of DAG in obese younger 
subjects. Our results are in contradiction with Bruce et al (118) who observed a trend towards the 
reduction both in the total DAG content and the saturated DAG species in young obese insulin-
resistant subjects after eight weeks of moderate exercise training. To the contrary, athletes had a 
two-fold higher concentration of total DAG within skeletal muscle than the obese subjects. Ours 
is the first study to report that total DAG content is actually higher in athletes. 
We did not find significant differences in muscle oxidative capacity and fiber type 
distribution between normal weight and obese groups.  This is in accord with a prior study by 
Kelley and colleagues (120) who observed no significant differences in fiber-type proportions 
between obese and lean middle-aged subjects. On the other hand our results contradict former 
studies showing that lean subjects had significantly higher proportions of type I fibers than obese 
(121) or that the degree of obesity was related with the proportion of fiber type (122), although 
both these studies did not control for habitual physical activity.  
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5.3 EFFECTS OF CHRONIC EXERCISE ON INSULIN RESISTANCE AND IMCL 
IN OLDER SUBJECTS 
The primary purpose of the third specific aim was to determine whether or not chronic exercise 
training is associated with insulin resistance in older subjects independently of obesity. We first 
hypothesized that endurance-trained athletes would have greater skeletal muscle insulin 
sensitivity compared to age matched sedentary normal weight subjects independently of their 
total body fat. This hypothesis was confirmed as endurance-trained athletes had higher insulin 
sensitivity compared to the sedentary subjects even after accounting for the residual effect of the 
last acute bout of exercise on insulin sensitivity. This was true only for peripheral insulin 
sensitivity as both groups presented similar hepatic insulin sensitivity. Thus after accounting for 
both age and total body fatness, chronic physical inactivity was associated with insulin resistance 
in older subjects. These data are in accord with many prior studies demonstrating an effect of 
chronic exercise to improve insulin sensitivity in younger and older subjects (9, 18). 
Furthermore, we recently reported that masters athletes had comparable levels of insulin 
sensitivity to younger athletes (Amati, Diabetes Care in press). Thus after accounting for both 
obesity and level of chronic physical activity, aging per se may not be associated with insulin 
resistance. These findings corroborate a recent study by Lanza and al (123) that suggested that 
“reduced insulin sensitivity is likely related to changes in adiposity and to physical inactivity 
rather than being an inevitable consequence of aging”. 
We also looked at markers of metabolic flexibility, corresponding to the ability to switch 
from mostly fat oxidation in the fasting condition to carbohydrate oxidation in the insulin 
stimulated condition. We found that master athletes were significantly more metabolically 
flexible than normal weight sedentary subjects, as the magnitude of their switch from more fat 
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oxidation to carbohydrate oxidation within the two conditions was higher for both substrates. 
These data are also consistent with our observation that the athletes had higher oxidative capacity 
in muscle, which is supported by extensive previous research demonstrating that exercise 
training in younger and older subjects increases the capacity for skeletal muscle fat oxidation 
(47, 50, 77, 124). The athletes had higher proportion of type I fibers, which is also supported by 
many reports in the literature (125, 126, 127).  
We also hypothesized that higher skeletal muscle insulin sensitivity in master athletes 
would be observed in the context of higher intramyocellular triglycerides but with lower levels of 
lipid metabolites, including diacylglycerol and ceramides, compared to sedentary normal weight 
older subjects. Both intramyocellular lipids measured in-vivo in the calf muscle and 
intramyocellular triglycerides measured ex-vivo in the thigh muscle were higher in the athletes 
than in their sedentary counterparts. This is the first study to confirm the athletes paradox (18) in 
older subjects.  
Surprisingly, we did not find significant differences between the athletes and normal 
weight sedentary older subjects with respect to total muscle content of ceramides or DAG. This 
is in accord with Helge and colleagues who observed similar muscle ceramide content in 
endurance trained compared with untrained normal weight young men (128). These same 
investigators found similar ceramide concentration in skeletal muscle from middle aged men 
over a wide variety of insulin sensitivities including type 2 diabetics, impaired glucose tolerant 
and normal glucose tolerant subjects (129). 
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5.4 INSULIN SENSITIVITY AND PATTERN OF DISTRIBUTION OF THE 
DIFFERENT SPECIES OF CERAMIDES AND DIACYLGLYCEROLS  
A novel aspect of this study is the description of virtually all of the molecular species of both 
diacylglycerol and ceramides in muscle of normal weight, obese and athletic human subjects. 
Our data strongly suggest that not all diacylclycerols or ceramides are the same with respect to 
how they relate to insulin resistance. We could hypothesize that based on their biochemical and 
molecular structure some of these fatty acid metabolites interact with the insulin signaling 
cascade while others not, therefore having different impacts on insulin resistance. The different 
subgroups of these complex lipids within muscle were based on whether they were higher in 
obese subjects or in athletes.  Thus, one could view these subgroups as “favorable” or 
“unfavorable” according to their specific associations with insulin resistance. These arbitrary 
classifications did not seem to be related to the level of fatty acid saturation or of length of the 
carbon chains. Furthermore, we demonstrated that the proportion of the “favorable” ceramide 
and diacylglycerols to the total amount of intramyocellular triglycerides was negatively 
associated with insulin resistance (R2=0.39, P=0.002 and R2=0.30, P=0.009 respectively).  More 
research needs to be performed to examine possible reasons to explain why some species of 
diacylglycerols and ceramides are related to insulin resistance while others not or may even 
confer higher insulin sensitivity. 
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5.5 LIMITATIONS 
This study was not without limitations. First our sample sizes are relatively small. Based on our 
power computations, our desired sample size for the normal weight sedentary older subjects was 
9, therefore we achieved a recruitment of 78%. In part this limited recruitment was due to the 
fact that, in the attempt to have a balanced gender ratio, we closed earlier the recruitment to 
women. Although this calls for a limited power in the first specific aim, it is important to note 
that our results for that comparison are confirmed by another recent study (123). 
The second limitation is related to the use of retrospective data for two of the four groups. 
In order to limit as much as possible the bias in the selection of the subjects in the retrospective 
data, the selection criteria were define in advance and subjects were selected in a blind manner.  
An important element to take into account is the amount of physical activity performed 
by the Masters athletes. These were enrolled if they were doing at least five sessions per week  
of endurance exercise. Nearly all of these subjects were training for competition at the time 
of testing and were performing much more exercise than is generally prescribed for the average 
population (31) . Therefore this study does not allow us to extrapolate these findings in athletes 
to more moderate physical activity as emphasized for general health. Thus the possibility 
remains that there is some threshold level or dose-response effect of physical activity on insulin 
sensitivity.  
This study also does not allow us to address an important and controversial question in 
the field of exercise physiology: “ Is fitness or fatness more important in determining 
cardiometabolic risk”? (130-132). On one side of the controversy it is hypothesized that it is not 
obesity per se that is deleterious for health but rather due to the likelihood that obese persons 
exercise less or are limited to perform the same amount of physical activity. Our study provided 
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important clues in a cross-sectional design that probably both fitness and fatness are important 
determinants of insulin resistance. To more fully answer this question, we have data to support 
that exercise and weight loss interventions each independently improve insulin sensitivity in 
previously sedentary obese older adults (9, 133) (and unpublished data).  
It is also important to note that all studies recruiting older subjects through advertisement 
are prone to some level of selection bias in the fact that the responders to the ads are typically 
subjects receiving medical care and that are interested in their health. One example to illustrate 
this point is that 100% of the recruited subjects in this study had regular check-ups with their 
primary care physicians. In addition, many of these subjects were being treated with lipid 
lowering medications (statins), which may explain that we did not see any differences between 
younger and older subjects in regards of their lipid panel. Therefore, a generalization of these 
conclusions to other populations, such as underserved or under medicated, needs to be avoided.  
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5.6 CONCLUSIONS 
We conclude that age per se does not influence insulin sensitivity in subjects matched by body 
fatness and physical inactivity. We can also deduce that obesity is associated with insulin 
resistance among older subjects after accounting for chronic physical inactivity. We can also 
conclude that chronic exercise positively influences insulin sensitivity after accounting for age 
and body fatness. Therefore, by carefully controlling age, chronic exercise (sedentary vs. 
athletes) and total body fat, the present investigation indicates that insulin resistance is associated 
with acquired conditions, including obesity and physical inactivity, but not with aging per se.  
Another key aspect of this study was to describe for the first time in subjects with widely 
different levels of insulin sensitivity the content and composition of intramyocellular lipids and 
their potential link to insulin resistance. We clearly demonstrated that ceramides within skeletal 
muscle are higher in obesity. However, the distribution of the various molecular species of these 
complex lipids is different in obese insulin resistant subjects compared to insulin sensitive 
normal weight athletes. We found that athletes have a different molecular species distribution of 
diacylglycerols and ceramides within the intramyocellular lipid pool. This suggests that ectopic 
fat deposition within muscle may be dependent on the oxidative capacity or metabolic flexibility 
of the individual or on the dynamic state, i.e., conditions of low vs. high energy flux or 
mobilization.  
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5.7 RECOMMENDATIONS FOR FUTURE RESEARCH 
Based on the findings of the present investigation and its limitations, future studies on  the 
effects of exercise, obesity and aging on insulin sensitivity and skeletal muscle lipid content 
should focus on the following: 
- Although our first comparison between younger and older normal weight sedentary 
subjects showed that insulin resistance was not influenced by age per se, this does not rule out 
possible differences in the etiology of insulin resistance between older and younger persons 
which need to be examined. In other words, it is possible that younger and older people develop 
insulin resistance in different ways according to some aging effect. Furthermore, differences in 
the extent or degree to which insulin resistance can be improved in both younger and older adults 
needs further investigation.   
- A possible dose-response effect on the amount of physical activity to achieve 
improvements in sedentary subjects has not yet been identified, either in younger or older 
subjects. Therefore, further investigations on the threshold or dose-response effects of physical 
activity on younger and older adults are warranted. Comparisons of insulin sensitivity 
improvements due to more moderate exercise programs to that of Masters athletes who have 
been exercising for many years would be a good dart to address this question.  
- An increased capacity for fat oxidation has been associated with insulin sensitivity and 
possibly to a greater utilization of IMCL, but the dynamic aspect of the content of IMCL related 
to the acute utilization of this substrate store has not been adequately explored. Observational 
studies examining the partitioning and alterations in the different species of fatty acid 
metabolites before and after an acute bout of exercise would shed light on how quickly muscle 
ectopic stores are remodeled and the impact of this remodeling on insulin sensitivity.  
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- In vivo non invasive techniques such as 1H-MRS are still limited in the quality of the 
spectra depending on particular characteristics of the subjects. Obesity and older age are 
characteristics that contribute to the poor quality of 1H-MRS spectra to quantify IMCL in vivo. 
The exploration and quantification of IMCL and other metabolites in higher field MR scanners 
may overcome these anatomical and physical limitations. Therefore, the further development of 
non invasive MRS methods should aid in this endeavor.  
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APPENDIX A 
ABBREVIATIONS LIST 
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Abbreviation Definition 
M Men 
W Women 
BMI Body mass index 
DXA Dual-energy X-ray absorpiometry 
FFM Fat free mass 
FM Fat mass 
Fat% Proportion of body fat 
Rd Rate of glucose disposal 
HGO Hepatic glucose output 
OGTT Oral glucose tolerance test 
NGT Normal glucose tolerance 
IGT Impaired glucose tolerance 
T2DM Type 2 diabetes 
NFG Normal fasting glucose 
IFG Impaired fasting glucose 
IR Insulin resistance 
IMCL Intramyocellular lipids 
IMTG Intramyocellular triglycerides 
DAG Diacylglycerols 
Cer Ceramides 
ORO Oil red O staining 
SDH Succinate deshydrogenase staining 
MR Magnetic resonance 
MRI Magnetic resonance imaging 
1H-MRS Proton magnetic resonance spectroscopy 
CT Computed tomography 
VAT  Visceral adipose tissue 
ScAAT Subcutaneous abdominal adipose tissue 
TAAT Total abdominal adipose tissue 
WC Waist circumference (tape measured) 
VO2peak Peak oxygen uptake 
RQ Respiratory quotient 
REE Resting energy expenditure 
Cho-ox Systemic carbohydrate oxidation 
Fat-ox Systemic fat oxidation 
EF Energy derived from fat 
SBP Systolic blood pressure 
DBP Diastolic blood pressure 
HbA1c Glycosylated hemoglobin 
IRB Institutional review board 
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APPENDIX B 
INCLUSION/EXCLUSION CRITERIA 
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INCLUSION CRITERIA 
INCLUSION CRITERIA YES NO Notes 
60-75 years of age    
Stable weight (No Gain/Loss of > 10 lbs in 6 months)    
Sedentary (≤ 1 continuous exercise/week) 
Or highly trained (>5 exercise sessions/week since 
≥1year) 
   
Non-smoker    
BMI 18-38.0 KG/M2    
Resting Blood Pressure ≤ 150mmHg systolic and ≤ 95 
mmHg diastolic 
   
Normal Glucose Tolerance: Fasting Glucose < 100 
mg/dl or 2 hour glucose from OGTT < 140 mg/dl  
   
Note from PCP/Cardiologist for exercise clearance if 
positive stress test symptoms were observed from GXT 
   
 
 
EXCLUSION CRITERIA 
 
EXCLUSION CRITERIA YES NO Notes 
Clinically significant CVD including h/o MI    
Peripheral Vascular Disease    
Hepatic, renal, muscular/neuromuscular, or active 
hematologic/oncologic disease 
   
Clinically diminished pulse     
Presence of bruits in lower extremities    
Previous history of pulmonary emboli    
Peripheral Neuropathy    
Currently not engaged in a regular program and have a 
VO2 max pre-training value > 55 ml/kg-fat free mass-
min., indicative of moderate fitness. 
Or Currently engaged in regular program and having a 
VO2 max value ≤ 55 ml/kg-fat free mass-min. 
   
Anemia (Hematocrit <34%)    
Any contraindications to moderate exercise 
(Please specify) 
   
Inability and/ or willingness to comply with the protocol 
as written 
   
Active alcohol or substance abuse (Past 5 Years)    
Total cholesterol >300 mg/dL    
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Triglyceride >350 mg/dL    
ALT >80, AST>80, Alk Phos >240    
Proteinuria (defined as > 1+ on routine dipstick)  
hypothyroidism (sTSH>8) 
   
Therapeutic Doses of Nicotinic Acid    
Impaired Glucose Tolerance (fasting glucose > 100 
mg/dl <  126 mg/dl or 2 hour glucose from OGTT > 
140mg/dl but less than 200 mg/dl or 
Type 2 Diabetes: Fasting Glucose > 126 mg/dl or 2 hour 
glucose > 200 mg/dl 
 
 
 
 
 
 
 
 
 
 
Oral glucocorticoids    
Females currently on hormone replacement therapy 
(HRT) less than 6 months 
   
Claustrophobia    
 Previous difficulty with lidocaine or other local 
anesthetic 
   
Stress test symptoms:  
• Positive ECG (> 2mm ST segment depression) 
without PCP cardiologist permission to 
participate 
• Signs or symptoms of cardiovascular 
decomposition  (hypotensive response to 
exercise) 
• Onset of angina or angina like symptoms, 
shortness of breath, change in heart rhythm, 
signs of poor perfusion (light-headedness), 
tightness,  
• Hypotension 
• Other 
   
 
STRESS TEST RESULTS YES NO Notes 
Clearance obtained by study cardiologist 
 
MD Name: ___________________________________ 
 
   
Clearance obtained by Participant’s PCP/Cardiolgist 
 
MD Name: ___________________________________ 
 
   
 
Participant Eligible?________________Yes    ____________________No 
 
If NO, note specific exclusion criteria:_____________________________________________________ 
 
Study Coordinator_______________________Date______________________ Initials_______________ 
Study Physician_________________________Date:_____________________  Initials________________ 
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APPENDIX C 
IRB APPROVED FLYERS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 93 
C.1 RECRUITMENT FLYER FOR ATHLETES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 94 
C.2 RECRUITMENT FLYER FOR SEDENTARY SUBJECTS 
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APPENDIX D 
IRB APPROVED RECRUITMENT LETTERS 
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APPENDIX E 
IRB LETTERS OF ACCEPTANCE 
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APPENDIX F 
IRB APPROVED INFORMED CONSENT FOR SCREENING 
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APPENDIX G 
IRB APPROVED INFORMED CONSENT FOR ATHLETES 
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